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ABSTRACT 
 Accurate quantitation of analytes in simple or complex matrices is imperative for detailed 
understandings of biological or synthetic systems and is also necessary to ensure consumer 
safety with regards to food, pharmaceutical formulations, and environmental hazards. Liquid 
chromatography-mass spectrometry (LC-MS) is capable of completing such tasks using a variety 
of quantitative methods. In Chapter 1, these methods are presented with regards to chemical 
warfare agent studies.  
External calibration, arguably the simplest of these techniques, quantifies an analyte by 
comparing the analyte’s response in the sample matrix to the analyte’s response in standard 
solutions. The success of this method hinges upon the consistency of the analyte’s response 
between the blank and matrix samples. The work in Chapters 2 and 3 is an investigation into 
causes of inconsistency in an analyte’s LC-MS response, namely matrix effects and nonspecific 
vial adsorption. Several case studies were performed highlighting the importance of 
incorporating vial adsorption studies into the method development stages of external calibration 
experiments. 
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CHAPTER 1 
INTRODUCTION TO LC-MS QUANTITATIVE METHODS 
1.1 INTRODUCTION 
 The use of liquid chromatography-mass spectrometry (LC-MS) has skyrocketed since the 
invention of electrospray ionization (ESI)
1,2
 and atmospheric pressure chemical ionization 
(APCI)
3
. These interfaces allow for the LC to be easily coupled to the MS, creating a powerful 
instrument capable of both separation and identification of a wide range of target compounds in 
an assortment of sample matrices. LC-MS can also be utilized to provide quantitative 
information using a variety of techniques. Quantitative applications of  LC-MS are quite diverse 
including quality control for food
4
, environmental
5
, and pharmaceutical samples
6
; proteomic
7
, 
metabolomics
8
, and genomic
9
 studies; biomedical diagnostic tests
10
; and forensic investigations 
such as toxicology
11
. A specific application falling under the previously listed categories is 
chemical warfare agent quantitation. The following encompasses a review of LC-MS 
quantitative analysis with respect to chemical warfare agents. 
Chemical warfare is not a new phenomenon. It has been documented as early as 
3000B.C.E. when the Egyptians investigated the lethal effects of plant poisons
12
. Large scale 
usage began during World War I with the development of several chemical warfare agents 
(CWAs)
12
. Chemical weapons used during this era had distinct odors or colors and could be 
detected by the human senses
13
; however, as new agents were created, this method of detection 
was deemed insufficient, and better ways to protect soldiers and civilians became imperative. 
Although detection of CWAs is the first goal when identifying a chemical warfare attack, 
quantitative data is also necessary to assess hazard levels, assist with containment and 
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decontamination, and determine the cause of death
14,15
. Consequently, improved techniques were 
developed to not only detect and identify chemical agents, but to provide quantitative 
information as well.  
One of the first detection methods developed was treated paper that could indicate the 
presence of a specific chemical.  Several types of detector paper were created; some of the most 
popular being M8 and M9
14
. These papers turned different colors in the presence of various 
chemicals including some CWAs
16
. There are several major downfalls to using indicator paper. 
The first being that the paper can give many false positives because the color change can take 
place in the presence of chemical interferents or due to prolonged exposure to heat
16
. In addition, 
indicator paper is not quantitative and only applies to liquid chemicals. 
Due to the need for more accurate detection of CWAs, a new technique started gaining 
popularity; ion mobility spectrometry (IMS). IMS was first introduced in the 1960’s with the 
first CWA application occurring in the 1970’s
17
. IMS separates ions based on their drift times in 
a buffer gas operated in an electric field where ions are separated based on their mass and charge, 
temperature, and the properties of the buffer gas
18
. Hand held IMS instruments have been 
developed that offer many advantages such as on-site and real time monitoring, and IMS is 
inexpensive when compared to other CWA monitoring techniques
19
. Hand held IMS 
instruments, such as the chemical agent monitor (CAM) and improved chemical agent monitor 
(ICAM), sample the air for CWA vapors and can be used to provide relative quantitation levels 
for airborne CWAs 
14
. However IMS instruments have limited selectivity due to similar drift 
times between ions, and response is affected by changes in humidity and temperature, making 
CWA quantitation difficult in extreme environments and complex matrices
20
. 
Gas chromatography- mass spectrometry (GC-MS) is the primary instrumental method 
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for detecting CWAs both in the Organization for the Prohibition of Chemical Weapons (OPCW) 
mobile laboratory and in off-site laboratories
21,22
. This technique offers both molecular mass 
information from chemical ionization (CI) and structural information from electron impact 
ionization (EI) making it the only approved stand-alone detection and quantitation technique by 
the Chemical Weapons Convention for on-site analysis of CWAs
23,24
. GC-MS is also the most 
widely adopted approach because it has high selectivity, low limits of detection (LOD), and can 
be used with spectral libraries
25
. Although many of the CWAs themselves are volatile, making 
them directly applicable to GC-MS, most readily degrade in aqueous matrices leading to the 
need for retrospective detection and quantitation in these instances
26
. The majority of the small 
molecule degradation products are not volatile making derivatization necessary
27
. Derivatization 
can cause loss of the analyte, giving rise to error in quantitative methods
27
.  Many of the matrices 
commonly under investigation in CWA studies are aqueous which requires matrix exchange 
before analysis by GC-MS
28
. Additionally, GC-MS is not directly amenable to large CWAs, such 
as ricin, or to CWA adducts with large molecules such as proteins
28
. 
Using LC-MS for CWA analysis in off-site laboratories offers a solution to some of the 
problems associated with analysis by GC-MS. Analytes used in liquid chromatography do not 
have to be volatile, alleviating the need for derivatization and allowing for direct investigation of 
nonvolatile CWAs or their degradation products. Aqueous matrices also do not have to undergo 
exchange to a more suitable solvent. Additionally LC-MS is applicable to analytes with larger 
molecular masses which opens up the possibility to quantify large CWAs and CWA adducts that 
are not able to be analyzed directly with GC-MS. As previously mentioned, many CWAs rapidly 
degrade in aqueous environments which makes their direct analysis by LC-MS a challenge, but 
the ability to directly analyze their nonvolatile products helps circumvent this problem
29
. 
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Consequently LC-MS is best suited for retrospective studies or studies involving large analytes. 
The system suitability of LC-MS is comparable to other analytical techniques for CWA 
studies. Recent advances of LC-MS have achieved LODs similar to those of GC-MS
30
. Another 
concern is whether or not LC-MS is able to achieve accuracy and precision levels that fall within 
an acceptable ±15% range. Several quantitation studies for CWAs have already been successful 
in reaching that goal
31,32,33
. However, at this time LC-MS is not accepted as a stand-alone 
technique for detection and quantitation of CWAs and must be supported with a complimentary 
method
34
. This chapter gives an overview of degradation products, metabolites, and adducts 
formed by CWAs, the matrices these compounds are frequently encountered in, followed by a 
more detailed perspective on how available LC-MS quantitation methods are used with CWAs 
and their associated matrices.   
 
1.2 CHEMICAL WARFARE AGENTS AND THEIR ASSOCIATED MATRICES 
 CWAs may be found in many different matrices, which can make detection and 
quantitation difficult. Furthermore, CWAs and the means to manufacture them are becoming 
more available to the general public
35
. In addition to chemical attacks, CWAs can also be 
released accidently from chemical stockpiles
36
. The North Atlantic Treaty Organization (NATO) 
has identified three time intervals in which CWAs need to be monitored: before, during, and 
after exposure
23
. Prior to CWA introduction, the analysis system serves as an early warning of 
toxic chemical release. Once a threat has been detected, the instrument can determine the 
concentration of the CWA which allows a responder to determine if the hazard poses an 
incapacitating or lethal effect. In addition to knowing the identity of the agent and exposure area, 
concentration information would also help responders determine what level of protection is 
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necessary, how long a worker could be safely in the environment, and what types of 
decontamination would need to be employed
14
. Additionally, the system should be capable of 
testing human samples to retrospectively confirm exposure to a particular agent. During these 
different time periods, CWAs would be encountered in an assortment of simple and complex 
matrices. LC-MS systems have been used to successfully quantify some CWAs, their 
degradation products, adducts, or metabolites in a variety of matrices as can be seen in Table 1.  
 
1.2.1 Environmental Matrices 
 The environment is a principal source of matrices for CWA quantitation. CWAs can be 
released into the environment either intentionally or accidentally. Intentional release can occur 
by several pathways, including aerosol spraying, dispersion by an explosion, heat induced 
vaporization, surface contamination, or adulteration of food or water
37,38
.  All of these release 
methods can result in the analyte being present in one or many different matrices, and every 
matrix presents a unique challenge to an analytical method. Recent studies have investigated 
CWA detection and quantification in a variety of matrices including snow
39
, office media
40
, 
beverages
33
, battlefield terrain
41
, clothing
42
, toxic waste
43
, fuel
44
, and food
45
. In addition to the 
previously noted release mechanisms, accidental release can also occur when chemical agent 
stockpiles are spilled or they leach into the environment. In these cases, concentration levels 
would need to be determined in matrices such as soil, water, or munitions samples
46
. Even 
though LC-MS has not yet been used to quantify CWAs in all of these matrices, it is a viable 
option. 
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Table 1 LC-MS Quantitation Studies 
Substance(s) Matrix Method 
Reported 
LOQ
† 
Linear 
Range 
Polarity Mode Ref 
VX* plasma 
structural 
analogues for 
IS* 
2 pg/mL 
0.5-100 
pg/mL 
positive MRM* 47 
VX 
plasma, 
blood 
combination
‡
 0.5 pg/mL 
0.5-300 
pg/mL 
positive MRM 48 
VX blood combination 750pg 
0.5-2000 
pg/mL 
positive MRM 49 
VX 
micro-
dialysate 
matrix-
matched 
0.002 
ng/mL 
0.002-1 
ng/mL 
positive SRM 50 
VX 
exposure 
discs 
SIL IS - 
5.0-1000 
ng/mL 
positive MRM 51 
i-BuMPA 
EMPA, 
IMPA, 
CMPA, 
PMPA 
urine combination - 
1-200 
ng/mL 
negative SRM 32 
EMPA, 
i-BuMPA, 
CMPA, 
IMPA, 
PMPA 
urine combination 0.5  ng/µL 1-200 ng/µL negative MRM 52 
IMPA, 
CMPA 
plasma SIL IS 5 ng/mL 
5 - 125 
ng/mL 
negative MS
1
 53 
IMPA serum 
external, SIL 
IS 
- - both MRM 54 
MPA, IMPA, 
EMPA, 
PMPA, 
CMPA, 
TDG, 
TDGO, 
TDGO2 
urine, 
saliva 
IS - 
10-500 
ng/mL 
positive MRM 55 
MPA water SIL IS 
0.25 
mg/kg 
- negative MS
1
 56 
EMPA, 
IMPA, 
PMPA 
water combination 
10, 5, 5 
ng/mL 
10-1000, 5-
1000, 5-
1000 ng/mL 
positive MS
2
 57 
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Substance(s) Matrix Method 
Reported 
LOQ
† 
Linear 
Range 
Polarity Mode Ref 
IMPA, 
iBuMPA, 
PMPA 
water 
structural 
analogues for 
IS 
- 
 
5-30 µg/mL positive MS
n
 58 
EMPA, 
IMPA, 
PMPA 
water 
structural 
analogues for 
IS 
0.2, 0.12, 
0.03 µg/L 
0.2-9, 0.12-
12, 0.03-20 
µg/L 
negative MS
1
 59 
MPA, 
EMPA, 
IMPA, 
CMPA, i-
BuMPA, & 
PMPA 
water, soil external - 
0.1-10 
µg/mL 
(except 
MPA 1-20 
µg/mL) 
negative SIM 46 
MPA, 
EMPA, 
IMPA, 
CMPA, & 
PMPA 
juice, 
water, cola, 
& milk 
matrix 
matched & 
SIL IS 
0.25, 0.5, 
0.25, 0.25, 
0.05 ng 
0.05-5 
µg/mL 
both MRM 33 
albumin 
adduct with 
GB, GD, and 
VX 
plasma combination 
0.01, 0.01, 
0.05 
ng/mL 
0.1-1000, 
0.5-1000, 
0.1-160 
ng/mL 
positive MRM 31 
BuChE 
adducts w 
GB, GF, VX, 
VR 
serum SIL IS - 
0.8-630 
ng/mL 
positive MRM 60 
BuChE 
adducts w 
GB, GF, VX, 
VR 
plasma SIL IS - 
1.0-510 
ng/mL 
positive MRM 61 
BuChE-VX serum SIL IS - 
4.0-510 
ng/mL 
positive MRM 62 
BuChE-VX 
water, 
hamburger, 
soil 
SIL IS - 
0.025 - 4.0 
ng/mL 
positive MRM 63 
SMO, TDG, 
TDGO, 
SBMTE, 
MSMTESE, 
SBMSE, 
SBSNAE 
plasma combination 
0.05, 5, 
0.5, 0.05, 
0.01, 0.01, 
1 µg/L 
0.05-500,  
5-500,  
0.5-500, 
0.05-500, 
0.01-500, 
0.01-500,  
1-500 µg/L 
positive SRM 64 
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Substance(s) Matrix Method 
Reported 
LOQ
† 
Linear 
Range 
Polarity Mode Ref 
SBMSE, 
MSMTESE 
urine combination - 
0.1-100 
ng/mL 
positive SRM 65 
SBMSE, 
MSMTESE 
urine combination 
10, 11 
ng/mL 
5-200ng/mL positive SRM 66 
SBMTE urine combination 
0.08 
ng/mL 
0.1-100 
ng/mL 
positive MRM 67 
SBSNAE 
urine, 
plasma 
matrix-
matched 
- 
0.5-5000 & 
30-3000 
ng/mL 
negative MRM 68 
albumin 
adduct with 
HD 
blood combination 4.5 nM 
0.1 to 10 
µM 
positive MRM 69 
albumin 
adduct with 
HD 
blood combination 4.5 nM 
5 - 30nM & 
100-1000 
nM 
positive MRM 70 
proteins 
affected by 
HD 
cell 
cultures 
SILAC - - both MS
2
 71 
EDEA, 
MDEA 
urine combination 30 pg 
1-500 
ng/mL 
positive MRM 72 
EDEA, 
MDEA 
urine SIL IS 
0.947, 
2.23 
ng/mL 
1.6-270 
ng/mL 
positive MRM 73 
EDEA, 
MDEA, TEA 
urine combination 
1, 3, 
10ng/mL 
1-500ng/mL positive MRM 74 
TEA, EDEA, 
MDEA 
wipes external 
73.2, 9.8, 
39.3 
ng/mL 
10-500 
ng/mL 
positive MRM 75 
CVAA, 
CVAOA 
urine 
matrix-
matched 
- 
0.5-1000, 
5.5-1090 
ng/mL 
negative MRM 76 
CVAA, 
CVAOA 
urine combination 
4.2, 4.6 
μg/L 
9.09–2895 
μg/L 
- 
evacu-
ated cell 
77 
CVAA, 
CVAOA 
urine external - 
1–100, 0.5–
100 ppb 
- 
dynamic 
reaction 
cell 
78 
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Substance(s) Matrix Method 
Reported 
LOQ
† 
Linear 
Range 
Polarity Mode Ref 
STX urine SIL IS - 
4.8-145.2 
ng/mL 
positive MRM 79 
STX water external 634 ng/L 
100ng/L to 
10µg/L 
positive MRM 80 
STX algae 
structural 
analogues for 
IS 
11ng/mL 
5-50 & 25-
200ng/mL 
positive MS
2
 81 
STX algae 
standard 
addition 
1789 pg 
10-100 
ng/mL 
positive MRM 82 
STX algae external - 1-50ng positive MID 83 
STX 
mussel 
extract 
external - 
2.87–8.61 
ng 
positive SRM 84 
STX seafood external - 0.3–64ng positive SIM 85 
STX seafood 
matrix-
matched 
5.7 µg/kg 
38.8-194 
ng/mL 
positive MRM 86 
ricin 
protein 
digest 
SIL IS - 
10-90 
fmol/µL 
positive MRM 87 
ricin 
water, 
milk, juice 
combination - 
10 – 10,000 
fmol/mL 
positive PIM 88 
ricinine urine combination 
0.083 
ng/mL 
0.083-832 
ng/mL 
positive MRM 89 
ricinine 
urine, 
blood, 
vitreous 
humour 
structural 
analogue for 
IS 
0.2 ng/mL 2-30ng/mL positive MRM 90 
ricinine 
serum, 
urine 
combination - 
15-60, 14-
60 ng/mL 
positive MS
1
 91 
ricinine urine combination - 
0.08-150 
ng/mL 
positive MRM 92 
ricinine feed external 15 pg 
5-1000 
ng/mL 
positive SIM 93 
† The LOQ’s reported here are identical to those published in each study. Various definitions were used 
to determine the LOQ, and in some cases, the method used to determine LOQ resulted in an LOQ that 
was higher than the reported linear range. For definitions please refer to the referenced articles. 
‡ Combination indicates the use of both matrix-matched and an internal standard as explained in section 
1.4.7. 
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* MPA, methylphosphonic acid; EMPA, ethyl methylphosphonic acid; IMPA, isopropyl 
methylphosphonic acid; CMPA, cyclohexyl methylphosphonic acid; PMPA, pinacolyl methylphosphonic 
acid; i-BuMPA, isobutyl methylphosphonic acid; EDEA, N-ethyldiethanolamine; MDEA, N-
methyldiethanolamine; SBSNAE, 1,1 -sulfonylbis-[2-S-(N-acetylcysteinyl)ethane]; SBMSE, 1,1 -
sulfonylbis-[2-(methylsulfinyl)ethane]; MSMTESE, 1-methylsulfinyl-2-[2-
(methylthio)ethylsulfonyl]ethane; CVAA, 2-chlorovinylarsonous acid; CVAOA, 2-chlorovinylarsonic 
acid; TEA, N-triethanolamine; STX, saxitoxin; SMO, bis-β-chloroethyl sulfoxide; TDG, thiodiglycol; 
TDGO, thiodiglycol sulfoxide; SBMTE, 1,1 -sulfonylbis[2-(methylthio)ethane]; TDGO2, thiodiglycol 
sulfone; BuChE, butyrylcholinesterase; GA, tabun; GB, sarin; GD, soman; GF, cyclosarin; HD, bis(2-
chloroethyl)sulfide; SIL, stable isotopically labeled; IS, internal standard; MRM, multiple reaction 
monitoring; SIM, single ion monitoring; SRM, single reaction monitoring; MID, multiple ion detection. 
 
1.2.2 Pharmaceutical Matrices 
 Another target matrix is pharmaceuticals. Several cases of intentional contamination of 
pharmaceuticals with CWAs have already been documented
94
. Although analyses of 
pharmaceuticals tainted with CWAs have been limited, LC-MS has been used to evaluate other 
types of contaminants and impurities in pharmaceutical samples making it relevant to CWAs
95
.  
 
1.2.3 Biological Matrices 
 LC-MS quantitative analysis is particularly applicable to biological matrices. Although 
most quantitative studies in biological matrices to date focus on studying the toxicity of the 
agent, another goal of LC-MS analysis is the accurate identification and quantitation of CWAs or 
their metabolites to help confirm an individual’s exposure to a CWA. To date the majority of the 
confirmations have taken place in post mortem samples
96
. The most common matrices to test 
CWA concentration levels after exposure are blood and urine due to their ease of collection
97
. 
Through a variety of analytical means, CWAs or their related products have been identified in 
tissue samples
98
, saliva
55
, skin
99
, and blister fluids
100
, however quantitation using these matrices 
may not provide an accurate reflection of an individual’s exposure level. In many of these 
matrices, the CWA degrades, forms an adduct, or is metabolized, making direct quantitation of 
11 
 
the CWA unrealistic, and an alternative compound for quantification must be chosen. 
 
1.3 CHEMICAL WARFARE AGENTS, DEGRADATION PRODUCTS, METABOLITES, 
AND ADDUCTS 
 A chemical warfare agent is defined by the OPCW as any toxic chemical or its precursor 
not intended to be used for peaceful purposes such as for completing industrial, agricultural, 
pharmaceutical, research, or protective goals
101
. The OPCW has divided these toxic agents into 
schedules associated with their hazard class
101
. These schedules can be further broken down into 
the types of toxicological effects the agents have on the body. Substances in schedule one are 
considered the most toxic. Schedule one contains chemicals that fall into the categories of nerve 
agents, blister agents, and toxins.  Many of the chemicals found in these categories are very 
reactive, making detection of the substances themselves a challenge and accurate quantitation 
impractical. Consequently many LC-MS based quantitation methods do not focus on quantifying 
the analyte directly, but instead use a more long lived degradation product, metabolite or adduct 
to retrospectively determine the concentration of the CWA. It should be noted that the 
production of degradation products, metabolites, and adducts for a particular CWA vary 
according to several factors including duration and method of exposure, dosage, and sample 
collection time, presenting a challenge when selecting an analyte to retrospectively quantify a 
particular CWA. Several comprehensive reviews have been written outlining degradation 
products, metabolites, and adducts used to identify CWAs
102,103, 29
. As a result, this section will 
only give a brief overview of CWA related compounds that have been used in LC-MS 
quantitative studies. 
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1.3.1 Nerve Agents 
 One of the most frequently studied groups of chemical agents is nerve agents. Nerve 
agents are organophosphorus compounds that irreversibly bind to the enzyme 
acetylcholinesterase (AChE)
104
. AChE hydrolyses the neurotransmitter acetylcholine (ACh)
104
. 
Excess ACh can result in overstimulation of muscles and eventually lead to paralysis
32
. Nerve 
agents can be split into two separate classes; the G-series and V-series. Commonly studied 
schedule one substances in the G-series include tabun (GA), sarin (GB), soman (GD), and 
cyclosarin (GF). While the most frequently studied agents in the V-series are VX and Russian 
VX (VR). 
 Organophosphorus nerve agents are highly reactive compounds making their degradation 
products the main targets during quantitative studies. In both environmental and biological 
matrices, hydrolysis products of the nerve agents are key degradation products to determine the 
extent of nerve agent exposure
103
. As can be seen in Figure 1, GB, GD, GF, VX, and VR 
undergo hydrolysis resulting in their corresponding alkyl methylphosphonic acid (AMPA)
59
. 
When these degradation products undergo a second hydrolysis reaction, the result is 
methylphosphonic acid
59
. At this stage none of the nerve agents can be distinguished from one 
another, however the rate of the secondary hydrolysis reaction is slow
26
. Additionally, in 
solutions with an alkaline pH, VX can also form a secondary hydrolysis product resulting from 
the cleavage of the O-C bond instead of the S-C bond
48
. GA can also undergo hydrolysis, but 
unfortunately its initial hydrolysis products are unstable and have not been used in any LC-MS 
quantitation studies
102
. Unlike using a GC, an LC based system does not require derivatization of 
AMPAs prior to analysis
103
. 
 
13 
 
 
Figure 1 Primary hydrolysis products of GB, GD, GF, VX and VR are isopropyl methylphosphonic acid 
(IMPA), pinacolyl methylphosphonic acid (PMPA), cyclohexyl methylphosphonic acid (CPMA), isobutyl 
methylphosphonic acid (i-BuMPA), and ethyl methylphosphonic acid (EMPA) respectively. Secondary 
hydrolysis product is methylphosphonic acid (MPA) for each agent. Adapted from references 33 and 46. 
 
 Retrospective quantitation is useful in cases when samples cannot be collected right 
away. For retrospective detection in biological samples, the hydrolysis products are relatively 
short lived because they are excreted from the body after a few days
102
. In blood, nerve agents 
form adducts with select proteins that can be measured up to a few weeks after exposure, making 
them a better choice for retrospective detection
102
. Soman, sarin, cyclosarin, tabun, and VX  
covalently bond to a tyrosine residue in albumin
31,105,106
. After the albumin is digested, it can be 
analyzed directly by LC-MS, and nerve agent exposure can be evaluated. One such study has 
used the tyrosine adduct to accurately quantify nerve agent exposure in rats
31
. 
The central targets for retrospective studies in biological matrices for the nerve agents are 
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adducts with butyrylcholinesterase (BuChE). BuChE is an enzyme that is similar to AChE, but 
present in a higher abundance in human serum
107
. BuChE forms an adduct with the nerve agents 
by binding at serine-198 residue, inhibiting BuChE’s activity
108
. A decrease in activity can be 
used to determine nerve agent exposure
60
. These adducts can persist for up to 16 days after 
exposure
108
. Measuring inhibited BuChE can take place by removing the phosphyl agent with 
fluoride ions and analyzing the fluorinated agent
109
 or by digesting the adducted enzyme and 
analyzing the peptide containing the serine binding site 
108
. However, the fluoride-reactivation 
method is impeded by spontaneous loss of alkyl groups from the attached agents making the 
reaction with fluoride unfavorable; a process known as aging
107
. Another problem for relating 
BuChE activity levels to nerve agent exposure is the starting levels may be highly variable in the 
general public
61
. However a few LC-MS quantitative studies have targeted BuChE for nerve 
agent exposure
60,63,61
. 
 
1.3.2 Blister Agents 
 The second group identified as schedule one chemical agents are blister agents. Blister 
agents, also known as vesicants, include a variety of substances that cause chemical burns to 
different extents
38
. Sulfur mustards, nitrogen mustards, and lewisites are blister agents that are 
categorized as schedule one agents. There are nine different types of sulfur mustards, three 
different nitrogen mustards, and three lewisites
101
. Although the exact biochemical processes 
behind sulfur and nitrogen mustard toxicity is unknown, these agents are believed to alkylate 
many cellular nucleophiles, including DNA, eventually causing cell death
110
. Lewisites bind to 
pyruvate dehydrogenase hindering the formation of acetyl coenzyme A
107
. Like nerve agents, 
blister agents are highly reactive making their degradation products targets for LC-MS studies.  
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 Out of the nine sulfur mustards listed as schedule one agents, bis(2-chloroethyl)sulfide 
(HD), is the most commonly studied. Subsequently, over ten degradation products and 
metabolites for HD have been identified and used in LC-MS quantitative studies. Figure 2 shows 
a schematic of the common degradation products and metabolites of HD. In environmental and 
biological matrices, HD can undergo hydrolysis, oxidation, or a combination of both to produce 
bis-β-chloroethyl sulfoxide (SMO), thiodiglycol (TDG), thiodiglycol sulfoxide (TDGO), and 
thiodiglycol sulfone (TDGO2)
26
. However TDG and TDGO have been detected at relatively high 
concentrations in unexposed individuals which limits their ability to be unambiguous 
biomarkers
111,112,113
. In addition to those degradation products, in biological samples HD can be 
metabolized by glutathione conjugation and undergo further oxidation or hydrolysis reactions to 
form mono and bis N-acetylcysteine conjugates, four of which are illustrated in figure 2
26,114
. 
One of these products, 1,1 -sulfonylbis-[2-S-(N-acetylcysteinyl)ethane] (SBSNAE), has been 
isolated in urine and used for HD quantitation
68
. The bis-N-acetylcysteine conjugates can 
undergo further metabolism by β-lyase to form 1,1 -sulfonylbis[2-(methylthio)ethane] SBMTE, 
which is readily oxidized to 1,1 -sulfonylbis-[2-(methylsulfinyl)ethane] (SBMSE) and 1-
methylsulfinyl-2-[2-(methylthio)ethylsulfonyl]ethane (MSMTSE)
67
. Usually SBMTE is analyzed 
as a result of SBMSE and MSMTSE being reduced with titanium trichloride (TiCl3) to a single 
product
67
. However one study has quantified SBMTE directly at very low levels in rat plasma
64
.  
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Figure 2 Schematic diagram for the degradation products and metabolites of HD, boxed in red. Analytes 
boxed in black have been used in LC-MS quantitation studies. Adapted from references 107 and 114. 
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As with the nerve agents, analytes with a longer lifetime are required to diagnose HD 
exposure. HD forms adducts with many nucleophiles in the body including proteins and DNA
103
. 
HD forms an adduct with both albumin and hemoglobin as well
115
, however current LC-MS 
quantitation studies have only used  the albumin adduct to retrospectively determine HD 
exposure 
69
.  
 The nitrogen mustards and lewisites are less commonly studied analytes because they 
pose less of a threat than sulfur mustard. A few quantitation studies have been completed on their 
hydrolysis products and oxidation products
76,75,72,77
. Figure 3 shows the hydrolysis products for 
the nitrogen mustards and figure 4 shows the hydrolysis and further oxidation products for 
lewisite one (L1). Nitrogen mustards hydrolyze to form their corresponding ethanolamines
102
. L1 
hydrolyzes to form 2-chlorovinylarsonous acid (CVAA) and then undergoes oxidation to form 2-
chlorovinylarsonic acid (CVAOA)
102
. Nitrogen mustards also form adducts with albumin, but 
this complex has not yet been a target of an LC-MS quantitative study
116
. 
 
 
Figure 3 Primary hydrolysis products of the nitrogen mustards A) Bis(2-chloroethyl)ethylamine (HN1) 
hydrolyses to form N-ethyldiethanolamine (EDEA).  B) Bis(2-chloroethyl)methylamine (HN2) 
hydrolyses to form N-methyldiethanolamine (MDEA). C) Tris(2-chloroethyl)amine (HN3) hydrolyses to 
form N-triethanolamine (TEA). 
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Figure 4 2-Chlorovinyldichloroarsine (L1) undergoes hydrolysis to form 2-chlorovinylarsonous acid 
(CVAA). CVAA is further oxidized to form 2-chlorovinylarsonic acid (CVAOA). Adapted from 
reference 76. 
 
1.3.3 Toxins 
 Toxins, unlike the other compounds listed as schedule one CWAs, are harmful substances 
produced naturally in biological systems
38
. Two toxins are listed in schedule one as chemical 
warfare agents, the first being saxitoxin (STX). STX is a small molecule with a molecular weight 
of 299.29 g/mol (Figure 5). It is a potent neurotoxin that binds sodium channels, consequently 
blocking sodium ions from entering the cell, and eventually leading to paralysis
38
. STX falls into 
the category of paralytic shellfish toxins because it is secreted by marine organisms such as 
cyanobacteria, dinoflagellates and algae
117
. Subsequently seafood and aqueous matrices are 
particularly applicable for LC-MS quantitation of STX. STX does not degrade rapidly, so it can 
be quantified directly by LC-MS, in positive ion mode
79
.  
 
 
Figure 5 A) Chemical structure of saxitoxin B) Chemical structure of ricinine 
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The second toxin listed as a schedule one chemical warfare agent is ricin. Ricin is a 
glycoprotein composed of two amino acid chains held together by a disulfide bond
118
. It inhibits 
protein synthesis in cells eventually leading to cell death
118
. Ricin is also a stable compound; 
consequently, it can be analyzed directly by LC-MS after proteolytic digestion
87
. However, many 
quantitation studies use ricinine (Figure 5) as a biomarker for exposure to ricin
89
. Ricin and 
ricinine both originate in the castor bean plant and ricinine can be analyzed without the need for 
proteolytic digestion, so it is frequently employed as the analyte of choice over ricin. LC-MS 
plays a major role in studies involving STX and ricin because these analytes cannot be analyzed 
by GC
28
. 
 
1.4 LC-MS QUANTITATION METHODS  
 LC-MS (and LC-MS/MS) offers a variety of quantitation methods for CWAs. A 
universal technique for CWA quantitation does not exist; consequently, choosing a method can 
be a complicated task. Methodology choice is based on the desired application with regards to 
the target analyte, matrix, and available resources. Additionally the type of quantitation desired, 
either relative or absolute, can impact decision making in determining which method is best 
suited for the quantitation goal. The next section focuses on methods that have been successfully 
employed in quantifying CWAs. A brief description of the principles behind each technique 
along with the advantages, disadvantages, and successful implementations of each method is 
given. 
 
1.4.1 External Calibration 
 LC-MS can use external standards to quantify analytes, in this approach, extracted ion 
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chromatograms (XIC’s) are used to measure the analyte ions’ abundance, and the concentration 
is determined using a standard curve. There are several situations and reasons where external 
calibration is particularly advantageous. The most important advantage to using external 
standards is that sample preparation can be minimized because incorporation of an internal 
standard is not necessary; making this technique favorable when a suitable internal standard 
cannot be found
119
. Additionally the sample is not made more complex by the addition of an 
internal standard. Since the sample is less complex, it allows for more MS/MS spectra to be 
gathered for the compound of interest
120
. Finally there is not a limit to the number of samples in 
which the amount of analyte can be quantified
120
.  
 External calibration is considered by some to be the least accurate absolute quantitative 
method available which can sometimes be the case
120
. The inaccuracy is because external 
calibration operates on the assumption that the ion intensity for the analyte will remain constant 
between the standard solutions used to construct the calibration curve and the matrix samples. 
However, ion intensity can be suppressed or enhanced between different types of matrices 
affecting the accuracy and reproducibility of this technique; a phenomenon known as matrix 
effects
121
. Matrix effects vary between analytes, matrices, and even between different lots of the 
same matrices (such as blood from two different victims) making them hard to predict. 
Regardless of this problem, external calibration can still be used in simple or uniform matrices or 
when matrix effects have been eliminated, or accounted for.  
 Degradation products of CWAs have been quantified using the external calibration 
technique. An interesting external calibration study investigated different types of wipes to swab 
surfaces for CWA contamination
75
. Degradation products of nitrogen mustard were spiked onto 
various surfaces including glass, wood, drywall, and vinyl then wiped with five different types of 
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materials. An external calibration curve was prepared using the peak areas of the degradation 
products. The different wipe materials used on each surface were then compared to the curve to 
determine which wipe most accurately collected the degradation products and had the least 
amount of background interferences. Several of the wipes showed contamination with the 
degradation products, which could lead to false positives or inaccurate quantitation of nitrogen 
mustard
75
. Using external calibration, filter paper wipes accurately quantified the degradation 
products encouraging their use when responding to exposure incidents. 
 As can easily be predicted from the downfalls of external calibration, this technique is 
most commonly employed for CWA quantitation in simple environmental matrices; the primary 
matrix being water
80,46
. The majority of external calibration techniques for CWAs are targeting 
STX. These studies are generally geared toward finding naturally occurring STX contamination 
in marine based samples, such as in seafood
85
 or algae
83
, because this poses a more serious threat 
than STX’s use a chemical weapon. However these methods could be adapted for chemical 
warfare testing. 
 
1.4.2 Matrix-matched Calibration 
 Matrix-matched calibration is a branch of external calibration that seeks to account for 
matrix effects in the sample. Instead of measuring the analyte’s response in a standard blank 
solution, the analyte’s response is measured in the same type of matrix as the unknown sample. 
Ideally the analyte will experience the same matrix effects in the standards that are experienced 
in the unknown, compensating for any matrix effects. Consequently matrix-matched calibration 
offers the same advantages as external calibration, but is also able to compensate for matrix 
effects. 
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 The matrix-matched calibration method has a few weaknesses. For this technique to be 
applicable, blank matrix has to be available, meaning matrix that does not contain the compound 
of interest and is the same type of matrix as the unknown sample
122
. Also this method works on 
the assumption that a relative matrix effect does not exist, in other words the matrix effect does 
not vary from lot to lot
123
. However relative matrix effects do exist, posing a potential problem 
with this method
123
. 
 Matrix-matched calibration is particularly applicable for food and beverage matrices 
because they are easy to obtain without CWA contamination. One such study analyzed the 
AMPAs of sarin, soman, cyclosarin, and VX in five different beverages including bottled water, 
cola, whole milk, and juice
33
. Matrix-matched calibration standards were made in each of the 
different matrices and then prepared for LC-MS/MS analysis by using solid phase extraction 
(SPE). The AMPAs were analyzed with multiple reaction monitoring (MRM) in negative ion 
mode. The authors reported better alleviation of ion suppression using the matrix-matched 
calibration than using isotopically labeled internal standards
33
. Matrix-matched calibration was 
also used to alleviate matrix effects experienced by STX in seafood matrices
86
.  
 Urine is easily obtained noninvasively and can be used for matrix-matched calibration in 
some CWA studies. Because CVAA and CVAOA are not naturally occurring in urine samples, 
good linearity and reproducibility can be obtained when performing matrix-matched 
calibration
76
. However in other instances urine is not suitable for use as a blank matrix.  One 
example of when this occurs is with TDG and TDGO since they are present in significant and 
varying concentrations in urine from non-exposed individuals. To verify HD exposure using this 
quantitation technique in urine, it is necessary to choose a different biomarker. One possible 
choice is a glutathione conjugate. The concentration of SBSNAE has been successfully 
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determined in urine from rats exposed to sulfur mustard using matrix-matched calibration
68
. 
 Nonvolatile compounds such as salt ions are particularly notorious for causing ion 
suppression in mass spectrometry
124
. Such ions are commonly present in microdialysate buffers 
leading to ion suppression in these samples
125
. Using a matrix-matched solution offers an 
alternative to compensate for ion suppression caused by a salty sample. Ringer’s solution is a 
composite of sodium chloride, potassium chloride, and calcium chloride in water
50
. This solution 
was used to compensate for matrix effects in an investigation of free VX in microdialysate 
samples obtained using blood probes
50
. As shown by the authors, the ability to use microdialysis 
as a sampling technique can provide a picture of VX concentration levels in blood over a given 
time frame without taking multiple blood samples
50
. 
 
 1.4.3 Standard Addition 
 The standard addition quantitation technique is a variation of matrix-matched calibration. 
Instead of using a blank matrix to create the calibration curve, the actual sample is used. The 
actual sample is divided into portions and known concentrations of the analyte are spiked into all 
the different portions except for one. LC-MS responses are then plotted against the added 
concentration, including the lot with nothing added. Linear regression is then used to extrapolate 
the best-fit line to zero
126
. The slope of the line and the y-intercept, the response for the 
unknown, can then be used to determine the concentration of the analyte in the original 
solution
126
. 
 Standard addition offers many of the same benefits as matrix-matched calibration. It 
corrects for both relative and absolute matrix effects without the need for a suitable standard 
other than the analyte itself. However, unlike the matrix-matched technique, it does not require 
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obtaining blank matrix. 
 Unfortunately the standard addition technique is limited by the original sample’s volume. 
A large starting volume is needed in order to be able to divide the sample into multiple lots. 
Consequently when the sample is in short supply, it might have to be diluted to obtain enough 
lots. In trace analysis, such as when working with CWAs, diluting the sample could cause the 
unknown’s response to become negligible when compared to the added amounts. Subsequently 
standard addition works best when an ample amount of the original sample is available.  
 Using standard addition to quantitate CWAs is most applicable to environmental matrices 
because the sample volumes are not as limited as with biological matrices. One LC-MS/MS 
study used standard addition to quantify STX in algae samples
82
. The application of this study 
was intended for naturally occurring environmental contamination, however this technique could 
be applied to the same analyte and matrix if used as a CWA. Although quantitation of STX was 
not the main objective of the study, it was shown that matrix effects are present in algae samples 
and standard addition can be used to accurately account for them
82
. 
 
1.4.4. Internal Calibration  
 Quantitation via internal calibration uses the same approach as external calibration with 
one key difference: Internal calibration utilizes a standard added to the sampling solution in a 
known amount to create a response ratio.  The ratio is a comparison of the mass spectrometric 
response between the analyte and the standard which can be determined via an XIC. Then a 
calibration curve is constructed by plotting the response ratio versus concentration. The curve 
and response ratio can then be used to determine the amount of analyte in an unknown sample. 
The goal of an internal standard is to account for the matrix effects, both relative and absolute, 
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variable recoveries, and instrumental fluctuations that might occur during trials by mimicking 
these changes that the analyte experiences
127
. Standards can either be structural analogues or 
stable isotopically labeled analogues of the compound of interest. 
 
1.4.4.1 Structural Analogues 
 Structural analogues of an analyte are frequently used to establish a calibration ratio in 
LC-MS quantitation studies. Structural analogues are compounds that are similar to the analyte 
but have a different mass and are varied at one or more moieties
128
. The best internal standard is 
one that has the most similar ionization pattern, recovery, and retention time of the analyte
129
. 
Another factor to be considered when choosing a structural analogue to serve as an internal 
standard, is whether the analogue can be found naturally in the matrix. Since a known amount of 
standard is added to the sample, it should not be naturally present, or the results will be skewed. 
The major caveat to this technique is that all analytes do not have a structural analogue that can 
be adequately used to mimic matrix effects
128
. Consequently a different technique would have to 
be selected.  
 A major benefit of using a structural analogue for internal calibration is that one standard 
can be used for multiple analytes, if those analytes all have similar retention times and ionization 
efficiencies as the standard. This characteristic was recently exploited to determine the 
concentration of AMPAs in water samples
59
. Diethyl phosphate (DEP) was used as an internal 
standard for three CWA degradation products, EMPA, IMPA, and PMPA. DEP had a similar 
retention time and chemical characteristics to the AMPAs in this study, and offered a less 
expensive alternative than an isotopically labeled standard or a standard for each individual 
analyte making it a suitable choice. When comparing this study to a similar GC-MS method, it 
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can be noted that the LOD’s along with the interday and intraday precision were comparable 
between the two methods, however using LC-MS avoids the derivatization step necessary for GC 
analysis
130
. 
 Two recent CWA studies highlight the importance of selecting a structural analog that 
has a retention time similar to the analyte. In the first study, fentanyl-d5 was selected as an 
internal standard for ricinine
90
. The chromatographic parameters used in this experiment, caused 
the standard and analyte to have retention times differing by over seven minutes
90
. In the blood 
matrix, this time difference caused the standard to experience more ion suppression than the 
ricinine which lead to inaccurate quantitation
90
. However in the less complex urine matrix, there 
was negligible ion suppression, so the large time difference was not a factor. The second study 
used VR as an internal standard to quantify VX in plasma
47
. Despite the complexity of the 
sample matrix, VR is able to be used successfully as a standard because of the structural 
similarity to the analyte leading to a retention time difference less than 30 seconds
47
. 
 
1.4.4.2 Stable Isotopically Labeled Standards  
 Stable isotopically labeled (SIL) analogues of the compound of interest can be used as 
internal standards (IS) for LC-MS quantitative methods. Commonly used isotopes include 
2
H, 
13
C, 
15
N, and 
17
O, although incorporating 
2
H has been shown to alter the retention time of the 
standard
131
. The standard usually contains three to eight isotopes in order for the mass difference 
between the standard and analyte to be large enough to avoid overlap, but retain the chemical 
properties of the analyte
131
. Additionally the standard should have high isotopic purity to prevent 
overlap with the naturally occurring isotopes in the analyte
131
.  
 Stable isotopically labeled analogues are favored over other compounds as internal 
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standards because of their chemical identity to the compound of interest. Chemical structure 
plays a role in the amount of ion suppression or enhancement a compound experiences making 
SIL compounds the best choice for an internal standard
132
. Since the standard and the analyte 
only differ by their masses, they elute from the LC at very similar times making both compounds 
susceptible to the same matrix components
128
. Ideally the SIL standard should experience the 
same ion suppression or enhancement the analyte encounters theoretically making it the most 
accurate method available
132
. 
 Despite the many benefits of using a SIL standard for quantitation there are a few 
drawbacks. First a SIL standard is not always commercially available, and when it is, it can be 
expensive. Also a different standard should be used for each analyte to ensure the best results. 
Finally cases exist where a SIL standard has been used and it has not successfully combated the 
matrix effects lowering the accuracy of the method
133
. However several successful usages of this 
method to quantify CWAs have been completed
52,72,32
. 
 Stable isotopically labeled standards used for internal calibration offers one of the most 
versatile techniques available to quantify CWAs. This method has been used in an assortment of 
matrices including plasma, urine, beverages, and water
53,79,33,56
. It is also applicable to a wide 
variety of analytes including schedule one CWAs and some of their degradation products and 
adducts. SIL standards are commercially available for many CWAs or their products, alleviating 
one of the problems associated with this method. 
 The SIL IS technique can be applied to determine exposure levels by monitoring the loss 
of an analyte. Prior knowledge of the analyte’s original concentration is necessary for this 
application, limiting this type of study to controlled environments such as toxicological research. 
This application of SIL IS has been developed for observing exposure levels in monkeys
51
. The 
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monkeys were exposed to a known amount of VX on stainless steel discs bandaged to their skin 
and after exposure their skin was swabbed with a cotton swab
51
. Residual VX quantities were 
determined on both the discs and cotton swabs by the SIL IS method. This information was used 
to estimate the dose of VX absorbed and then related to the effects that were observed.  
Another application of SIL IS quantitation is for bottom-up quantitation of proteins. 
Custom stable isotopically labeled peptides are commercially available, allowing for usage as 
SIL IS. Peptides resulting from protein digestion can be used to reflect the original protein’s 
concentration. Generally, one or more peptides are selected that are unique to the protein of 
interest and present in a fairly high abundance. Choosing to use more than one peptide can result 
in a more accurate representation of the protein’s concentration. One study quantified ricin by 
using this approach
87
. The authors’ main goal was to test digestion parameters in order to ensure 
complete digestion
87
. Incomplete digestion changes the m/z of the naturally occurring peptide, 
which causes an underestimate of its actual concentration. This application of SIL IS is of great 
importance because GC-MS platforms are not able to analyze peptides.  
 BuChE and BuChE adducts with organophosphorus nerve agents can also undergo the 
digestion and subsequent quantitation using isotopically labeled peptides. One study attached 
antibutyrylcholinesterase antibodies to magnetic beads that captured BuChE in serum samples
60
. 
Both adducted and unadducted BuChE were captured and then digested.  A peptide containing 
the binding site of the nerve agents was selected for use as a SIL internal standard because it 
could be used for both the adducted and unadducted compounds
60
. MRM mode was employed to 
allow for multiple analytes to be quantified, including adducts and the unadducted BuChE
60
. 
Being able to simultaneously quantify adducted and free BuChE is essential to determine the 
percent adducted BuChE without the need for prior knowledge of total BuChE levels
60
. This 
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quantitation approach effectively addresses the problem that the level of BuChE observed in 
different individuals is variable. Recently this process has been automated
61
. Additionally 
immobilized BuChE on magnetic beads can be used as a purification technique by binding to 
free nerve agents in an assortment of matrices; then the agents can be quantified using the 
previous process
63
.  
 
1.4.5 Echo Peak Calibration 
 A recently developed technique, known as the echo peak technique, is a branch of 
internal calibration, but uses the analyte itself as an internal standard. In this method, a standard 
is prepared using a known amount of the analyte. The standard and the unknown sample are 
injected consecutively within a short time frame giving rise to an echo peak
134
. Consequently the 
standard and analyte in the unknown sample will have close to the same retention time making 
both the standard and the sample’s analyte susceptible to the same matrix effects
134
. To quantify 
the analyte, a calibration curve is constructed in the same way as the internal standard method; 
using a ratio of the analyte to standard’s response versus concentration. 
 There are several assumptions made when using this method, which can lead to 
inaccurate quantitation. The first assumption is that the time frame where the matrix effects 
occur is large enough to encompass the peaks from the standard and the sample, so that both are 
experiencing the same level of matrix effects
135
. If the matrix effects occur only at the retention 
time of the one of the peaks, then ion suppression or enhancement will not be accurately 
accounted for. A second assumption is that the peaks do not exhibit tailing which could cause the 
signal of the second peak to be overestimated
134
. Sufficiently resolving the peaks from each other 
would solve that problem, but any increase in the time difference between the two peaks could 
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cause the matrix effects experienced to change.  
 Echo peak calibration has several benefits. Creating an echo peak does not require 
finding a suitable compound to use as a standard, but in most cases it is still able to compensate 
for matrix effects. Consequently, the method development phase for this technique is faster than 
using a structural analogue or SIL analogue as an internal standard
135
. Since this technique is 
relatively new, it has not yet been used to quantify CWAs. However, it has been used for 
pesticide quantitation including some organophosphate pesticides which are in the same 
chemical class as nerve agents
135
. 
 
1.4.6 Metabolic Labeling  
 If a protein or a peptide in a cell is being used for quantitation, then a branch of 
techniques called metabolic labeling can be employed. Metabolic labeling incorporates a stable 
heavy isotope to the protein/peptide of interest by growing it in a cell in isotopically enriched 
media
136
. A second set of samples is grown without the enriched media, and then the samples are 
combined and analyzed by LC-MS. Metabolic labeling techniques provide relative quantitative 
information meaning they do not provide the exact concentration of the analyte, but compare it’s 
abundance between the control and experimental groups.  
 
1.4.6.1 Stable Isotope Labeling by Amino Acids in Cell Culture  
 Stable isotope labeling by amino acids in cell culture (SILAC) by first described in 
2002
137
. This method of metabolic labeling incorporates a stable heavy isotope to the 
experimental group by using media that only contains isotopically labeled essential amino acids. 
Since only isotopically labeled amino acids are available to the cell, the cell translates proteins 
31 
 
containing only isotopes. The control group is grown in media that contains natural amino acids 
leading to the development of heavy and light proteins. Heavy and light strains are mixed in 
equal ratios prior to being digested for LC-MS analysis. The heavy and light versions of the 
same peptide will co-elute from the LC because they have identical structures, but they can be 
easily distinguished by their difference in mass. By comparing the ion intensities between the 
labeled and unlabeled peptides, relative quantitative information can be gathered about the 
abundances of the two samples.  
 Due to the similarity between using stable isotopes for internal calibration and using them 
for SILAC, these techniques offer some of the same advantages. Once again the analyte and the 
labeled compound elute at the same time and have the same ionization efficiency essentially 
eliminating matrix effects as a problem. The isotopically enriched media used for SILAC is 
commercially available, alleviating the problem of finding an isotopically labeled standard. 
Additionally SILAC provides information about what is happening to the chemical agent in vivo. 
 SILAC is not applicable for many desired goals of CWA quantitation. For instance 
SILAC only provides relative quantitation information and frequently the absolute concentration 
is needed. Furthermore, SILAC can only be applied to biological samples and still those samples 
are limited to proteins in the cell. Also this technique is slow compared to other quantitation 
methods such as external and internal standard calibration because cells have to be grown. 
Consequently, it is not useful when rapid information is necessary such as before or during 
exposure to CWA. However, it is effective for toxicological studies to determine how CWAs 
react in the cell.  
 A recent study by Everley and Dillman used SILAC to investigate phosphorylation 
changes in cells exposed to sulfur mustard
71
. Using the light and heavy conditions, proteins were 
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monitored in the cell to identify which were up regulated, down regulated, or not affected by 
sulfur mustard exposure. Eighty-six proteins were identified that showed greater than 2-fold 
concentration changes, some of which had been identified in other studies, but numerous had not 
been previously characterized
71
. Using the relative quantitation information gathered during the 
experiment, Everley and Dillman were able to create a network map relating proteins with 
altered concentrations due to sulfur mustard exposure to the cellular processes the protein is 
involved in
71
. This map is useful because it provides evidence for sulfur mustard’s toxicological 
mechanisms in cellular systems giving rise to potential therapeutic targets. 
 
1.4.7 Combinational Methodology 
 Matrix effects, insufficient and variable recovery, instrumental fluctuations, and 
inconsistent analyte stability may be difficult to entirely account for using a single quantitation 
technique leading to low reproducibility, accuracy or precision. The difficulty encompassing the 
previously listed factors is most frequently encountered in extremely complex matrices such as 
blood or plasma. In instances where quantitation is deemed insufficient using a single method, 
two methods can be combined to reach the desired level of accuracy or precision.  The most 
common combination of methods utilized in CWA studies is incorporating an internal standard 
into matrix-matched calibration. Either a structural analog or a SIL standard can be employed. 
The disadvantage of using a combination of methodologies is that both blank matrix and an 
appropriate internal standard have to be obtainable. However, as can be seen in Table 1, using a 
combination of techniques is the most widely utilized methodology for CWA studies.  The 
following section highlights several examples where a combination of methods was used for 
quantifying CWA’s. 
33 
 
 Structural analogs have been used in conjunction with blank matrix to improve method 
few accuracy in a few CWA investigations
64,49,57,48
. One of these methods simultaneously 
monitored the levels of seven different metabolites of HD in plasma from an exposed rat using 
blank plasma and comparing each metabolite’s response to a single structural analog
64
. 1,1-
sulfonylbis[2-(ethylsulfinyl)ethane] (SBESE) was used for the structural analog, which was 
particularly advantageous because it eluted in the middle of the chromatographic run making it a 
good fit for both early and late eluting analytes
64
. Using the blank matrix helped to account for 
absolute matrix effects experienced in the plasma samples, lowering the need for the internal 
standard to have a very similar retention time to each analyte. The internal standard corrected for 
relative matrix effects, changes in recovery, and instrumental fluctuations between each run. This 
method was used for a time course study on the concentration of each metabolite after HD 
exposure
64
. The information gathered from this study can be used to select the best biomarker 
during a particular time interval after exposure. 
 As with individual quantitation techniques, stable isotopically labeled standards can be 
used in combination with blank matrix to provide additional precision and accuracy. Two recent 
studies have utilized a combination of blank urine and commercially available stable isotopically 
labeled ricinine to examine ricinine levels in human urine samples
91,92
. The first method used this 
combination to verify an individual had self-administered castor bean extract which resulted in 
death
91
.  Another investigation using urine and commercially available standards determined 
ricinine’s ability to be used as a biomarker for ricin poisoning by assessing background levels in 
urine samples of unexposed individuals
92
. After analyzing almost 1000 urine samples, the 
author’s reported about 1.2% of the unexposed population has levels of ricinine of 4.15ng/mL or 
lower
92
. The individual who had been exposed to castor bean extract reported an initial urine 
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concentration of ricinine over 13 times as high (57.6 ng/mL) as the unexposed population
91
. 
Since such a dramatic difference in concentrations is present, ricinine can be used as a biomarker 
in urine for cases when concentration data can be compared with other information such as a 
patient’s symptoms, but caution should be exercised when confirming ricin poisoning when low 
levels of ricinine are reported. 
Blank urine and stable isotopically labeled standards were also used in combination to 
quantify AMPAs 
32
. The study in reference 21 reached LODs more than 10-fold lower than the 
AMPA concentration levels reported in a victim’s urine, highlighting the clinical relevance for 
using AMPAs as biomarkers for nerve agent exposure. The authors also reflected upon the 
importance of high throughput when detecting biomarkers for nerve agent exposure, due to the 
extreme number of samples that might be submitted to a lab after CWA release. Consequently, a 
goal of this analysis method was to have high-throughput, and analysis of almost 300 samples 
per day was achieved. Additionally when responding to an exposure incident, many different 
analysts would be handling samples. This study was completed by several different analysts, and 
no false positives or negatives were reported. The results were compared to a similar GC/MS/MS 
method and the LC/MS/MS method showed accuracy as good as or better than GC-MS/MS 
method.  
Using a combination of SIL internal standards and blank matrix has also been employed 
when the internal standard, blank matrix, or both were not easily obtainable. Bao et al quantified 
the covalent adducts of nerve agents with albumin using SIL standards, but these standards had 
to be synthesized in house
31
. In this same study, the albumin fraction purified from plasma 
samples was used as a blank matrix
31
. This combination was successfully used to quantify the 
tyrosine adducts of sarin and VX using deuterated O-(O-isopropyl methylphosphonyl) tyrosine 
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and deuterated O-(O-ethyl methylphosphonyl) tyrosine with limits of quantitation (LOQ) 
reached 0.05 ng/mL and 0.1 n/mL for sarin and VX, respectively
31
.  
A combination of methods more frequently uses blank matrix and a SIL internal standard 
as opposed to using a structural analog. Generally this quantitation technique is employed when 
both blank matrix and stable isotopically labeled standard are readily available. The vast majority 
of CWA applications using the combination technique were conducted in biological matrices, 
with the most common application quantifying ricinine in urine. This application is likely 
popular due to the ease of collection of blank urine and the commercial availability of ricinine. 
 
1.4.8 Method Comparison   
The ideal quantitation method is one that produces instantaneous results with 100% 
accuracy at extremely low concentrations for free. Experience in quantitative chemistry quickly 
reveals that such a method does not exist. Therefore experimenters must choose which factors 
are the most important for their particular study and generate a suitable balance between the 
different methods’ characteristics. Table 2 offers a comparison of LC-MS quantitation methods 
used for absolute concentration determination in CWA studies. Merits are highlighted in green 
while demerits are listed with red. In addition to the quantitation method’s characteristics, 
evaluating the sample matrix and the analyte or analytes greatly influence the method choice. 
The sample matrix has a large impact on which quantitation method is appropriate. The 
accessibility of blank matrix controls whether or not matrix-matched calibration can be used. In 
CWA studies, blank environmental matrices and biological matrices that are collected 
noninvasively are most easily obtained, lending themselves to matrix-matched calibration. 
However, the complexity of the matrix and its subsequent processing are the determining factors 
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Table 2 Quantitation Method Comparison 
 External 
Matrix-
matched 
Standard 
Addition 
Structural 
Analog 
SIL IS Combination 
Additional analyte 
required 
      
Blank matrix 
required 
      
Internal standard 
required 
      
Large sample 
volume necessary 
      
Corrects for absolute 
matrix effects 
      
Corrects for relative 
matrix effects 
      
Corrects for inter-
run variations 
      
Unlimited number 
of analytes 
      
 
for which quantitation method is necessary. For example, in very simple matrices, such as water 
samples, matrix-matched calibration is probably not necessary due to the low number of 
chemical interferences for CWAs even though blank matrix is readily available. In more 
complex samples, such as whole blood, the experimenter will have to decide if it is more 
advantageous to obtain blank matrix or use a standard to correct for matrix effects that may be 
experienced by the analyte. 
The identity and number of analytes influence the choice of an internal standard. If the 
goal is to quantify two or more CWAs or their products, selecting a structural analog that reflects 
the retention time and ionization of all the compounds can be used effectively. However if a SIL 
internal standard is available for each of the analytes, this can save time in selecting a structural 
analog. Stable isotopically labeled standards are commercially available for all the AMPAs, 
TDG, and ricinine along with labeled peptides for protein adducts or ricin. For the analytes that 
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do not have commercially available SIL internal standards, a structural analog can be used or a 
SIL IS can be synthesized.  
 
1.5 CONCLUSION 
 Exposure to chemical warfare agents is a possibility to both soldiers and civilians. 
Accurate quantitation information is necessary during an exposure incident to determine the 
hazard level which will assist responders with choosing the correct containment and 
decontamination procedures. In the future, quantitative levels in vivo may be used to supply 
medical personnel with the knowledge necessary to treat the victim and supply the adequate 
amount of antidote, if one is available. The high importance of quantitative information for 
CWAs in a variety of settings causes quantitative analytical strategies to continuously be 
improved.  
 Chemical warfare agent quantitation using LC-MS or LC-MS/MS offers a variety of 
opportunities not applicable when using other analytical techniques. LC-MS has the ability to 
quantify CWAs, their degradation products, and adducts without the need for derivatization. 
Many different methods to quantify these compounds are available, including use of external 
standards, with or without matrix-matched calibration, and stable isotopically labeled internal 
standards. Quantitation can take place in a variety of matrices including environmental and 
biological samples. Chromatographic retention time combined with the molecular weight 
information, along with diagnostic fragment ions gathered from tandem MS experiments, allow 
for irrefutable identification of the analytes being quantified. The diversity of quantitation 
procedures available combined with the low amount of sample preparation make LC-MS an 
unparalleled analytical tool for the quantitation of CWAs and their degradation products. 
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Consequently, LC-MS/MS provides enough information to become a stand-alone quantitation 
technique for CWAs.   
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CHAPTER 2 
SAMPLE / VIAL INTERACTIONS DURING QUANTITATIVE ANALYSIS 
 
ABSTRACT 
Sample/vial interactions are a well-known phenomenon, with many reports in the 
literature demonstrating that a variety of materials can absorb to vials of various types
1, 2, 3
.  
However, investigators will not detect such interactions unless they look for them specifically, 
and these interactions are rarely tested for in developing quantitative proteomic methods.  By 
contrast, tests for matrix effects are quite a routine aspect of quantitative method development.  
This report is a case study demonstrating examples of how sample/vial interaction can result in 
quantitative data that appears to be hindered by matrix effects, when, in fact, no matrix effects 
are present.   By demonstrating that vial interactions can produce outcomes consistent with a 
sample experiencing matrix effects, we provide analysts with information to help develop their 
quantitative methods when initial calibration results fail to provide acceptable data.  Additionally 
the data herein provide an important reminder to those doing quantitative analysis that glass 
autosampler vials are not inert; they may interfere with some analyses. 
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2.1 INTRODUCTION 
Mass spectrometry is quickly becoming the technique of choice for quantifying analytes 
in complex matrices. Absolute quantitation can be achieved using internal or external calibration. 
Internal calibration provides high accuracy, precision, and reproducibility by correcting for any 
changes experienced by the targeted compound in an internal standard
4
. However every analyte 
does not have an appropriate internal standard. In these and other instances, external calibration 
methods are used 
5
. 
One of the most well-known barriers to surmount while developing an absolute 
quantitation method by LC-MS using external standards is the problem of signal suppression and 
signal enhancement, otherwise known as matrix effects. The causes and mechanisms behind 
matrix effects are not yet fully understood, making them difficult to encompass in a quantitative 
method. However, one known cause of matrix effects is from a component of the sample matrix 
eluting at the same time as the analyte of interest. Co-elution affects the ionization efficiency of 
the analyte by suppressing, enhancing, or having no effect on the analyte’s signal. The degree of 
signal suppression or enhancement has been correlated to the concentration of the other 
components of the matrix, making complex biological samples especially prone to matrix 
effects
6
.  
Post-column infusion is one commonly employed approach used to monitor ion 
suppression and enhancement prior to the development of a quantitative method
7, 8
. This 
approach, first described by Bonfiglio et al., utilizes a tee splitter to combine the flow from the 
LC gradient with a continuous flow of analyte; the combined flow is directed to the source of the 
mass spectrometer
9
. Using this technique, it is possible to predict whether or not an analyte is 
susceptible to matrix effects at a particular retention time.  
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When there are no matrix effects impacting an analyte, or the matrix effects have been 
avoided, removed, or accounted for, analysts often proceed with developing quantitative methods 
by generating a calibration curve and running quality control samples, to verify the quality of the 
calibration results.  The external calibration approach has been successfully employed in a wide 
variety of applications including analysis of trace environmental contamination
10, 11
, biomedical 
samples
12
, food and beverage contamination
13, 14, 15
, illicit drugs
16
, and explosive residues
17
. 
Unfortunately, sometimes a successful calibration method cannot be developed, even 
after matrix effects have been deemed to be absent, because external calibration is susceptible to 
other sources of inaccuracy including variable extraction recoveries, instrumental fluctuations, 
and vial adsorption.   Despite this known problem, many of these factors are often disregarded 
during method development.  Optimizing recovery from sample containers is rarely assessed 
despite studies showing variable recovery from both long term storage containers
1, 2, 18
 and 
injection vials
3,
 
19
. The FDA’s guidelines for analytical method development and validation 
require extraction recovery and analyte stability to be assessed, but they do not require 
adsorption studies to be completed for the method to be fully validated
20
. Vial absorption or 
changes in adsorption levels throughout an experiment could lead to inaccurate quantitative 
results
21,
 
22
. 
The work described here is a quantitative investigation of leucine enkephalin, MRFA, 
bradykinin, and gestrinone in various matrices of tryptically digested proteins.  Amino acid 
sequences or structures of the analytes along with select physical properties are shown in Table 
1. Both vial adsorption and matrix effects were assessed.  While variability in the quality of the 
quantitative results initially suggested that matrix effects were present, these effects had been 
ruled out experimentally.  Vial adsorption was shown to be the major contributing factor in  
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Table 1 Physical Properties of Analyzed Compounds 
 
*pI values were estimated from the pKa values of isolated residues and could be altered from protein 
folding 
 
obtaining accurate and precise quantitation.  This case study highlights the importance of 
investigating adsorption, particularly when matrix effects are deemed to be absent, but 
quantitative data does not meet acceptable accuracy and precision requirements. 
 
2.2 EXPERIMENTAL 
 
2.2.1 Materials and Reagents 
Leucine enkephalin (YGGFL), MRFA, bovine serum albumin (BSA), lysozyme from 
chicken egg white, dithiothreitol (DTT), iodoacetamide (IAM), Trizma hydrochloride, Trizma 
base, formic acid, and glacial acetic acid were purchased from Sigma-Aldrich (St Louis, MO). 
 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg 
Compound 
Leucine Enkephalin 
MRFA 
Bradykinin 
Gestrinone 
log P Sequence/Structure pI
* 
5.50 
10.00 
11.97 
8.14 
-2.3 
-3.8 
-4.8 
2.2 
Tyr-Gly-Gly-Phe-Leu 
Met-Arg-Phe-Ala 
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Optima grade methanol and acetonitrile were obtained from Fisher scientific (Fair Lawn, NJ). 
Sequencing grade trypsin was purchased from Promega (Madison, WI). Bradykinin was 
purchased from Enzo Life Sciences (Farmingdale, NY). Gestrinone was purchased from Caymen 
Chemical (Ann Arbor, MI). Water was purified using a Millipore Direct-Q3 filtration system 
(Billerica, MA). 
 
2.2.2 Trypic Digestion 
Lysozyme and BSA were dissolved in pH 8.5 Tris buffer to give working solutions of 
approximately 6 mg/mL for each protein. The samples were reduced with 100mM DTT for 1 
hour at room temperature and then alkylated with 500mM IAM for 1 hour at room temperature 
in the dark. Alkylation was quenched by adding an additional aliquot of DTT and incubating for 
another 30 minutes at room temperature. Samples were digested with trypsin at a protein to 
enzyme ratio of 30:1 for 18 hours at 37°C. The digestion was stopped with the addition of glacial 
acetic acid at a volume of 1µL for every 100µL of sample. The subsequent digest samples were 
stored at -20°C until they were used as matrices for the infusion and quantitation experiments. 
 
2.2.3 Sample Preparation 
Stock solutions of YGGFL, MRFA, and bradykinin were made in 50:50 methanol to 
water with 0.1% formic acid to give a final concentration of ~200uM. Gestrinone was prepared 
in methanol with 0.1% formic acid with a final concentration of 3.25 µM. Calibration standards 
were prepared daily by serial dilution from the stock solution in water. Five points were chosen 
to construct the calibration curve over the linear range for each analyte. A quality control (QC) 
set was prepared by spiking each analyte into four different matrices. The matrices were water 
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(control), ~4.3 µM BSA digest, ~18.5 µM lysozyme digest, and a mixture of the BSA and 
lysozyme digests. Samples were placed in glass vials for autosampler injection. A second set of 
standards and QC samples of MRFA and bradykinin were also placed in polypropylene vials for 
injection. Stock solutions were stored at -20°C until diluted for LC-MS analysis. 
 
2.2.4 LC-ESI-MS/MS Analysis 
The analytes were injected in the following order:  One set of standards, followed by one 
trial of the QC set and then repeated (n=2). Each sample was injected with a volume of 5µL into 
an ultra-high performance liquid chromatograph (Waters Acquity, Milford, MA) and separated 
on a Hypersil GOLD column (C18, 100 mm X 1.0 mm i.d., 5 µM, 175 Å; Thermo Scientific, San 
Jose, CA). Mobile phase A was 99.9% water and 0.1% formic acid, while mobile phase B was 
99.9% acetonitrile and 0.1% formic acid. The analytes were eluted using the following gradient 
operating at a flow rate of 50 µL/min. Initially the mobile phase was 98% A and 2% B for the 
peptides. The initial mobile phase for gestrinone was altered to 90% A and 10% B because the 
analyte is not soluble in aqueous solutions. Mobile phase B was increased linearly to 60% over 
24 minutes and held there for 2 minutes. It was then returned to 2% B and maintained for 4 
minutes to reequilibrate the column. A blank was run between each sample to minimize the 
analyte carryover. 
Detection was carried out on a LTQ Velos dual linear ion trap mass spectrometer 
(Thermo Scientific, San Jose, CA) operating in positive ion mode. The eluent was infused into 
the mass spectrometer via an electrospray ionization source. The source used a spray voltage of 3 
kV and had a capillary temperature of 250° C.  Extracted ion chromatograms of the MS data 
were used to construct calibration curves.  
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2.2.5 Post-Column Infusion 
Post-column infusion was set up as described by Bonfiglio et al (Figure 1)
9
. 
Approximately 5µL of matrix was injected into the LC-MS system and ran under the conditions 
described above. The eluent was directed toward a T-splitter using PEEK tubing where it was 
continuously infused with the analyte. Both were then directed to the ESI source. The analyte 
was pumped at 5 µL/min using a Harvard Apparatus Pump 11 (Holliston, MA) to give a 
concentration at the source of ~200nM for the peptides and ~3.5nM for gestrinone. The signal 
fluctuation for each analyte was monitored throughout the runs using MS
1
 data.  
 
2.2.6 Quantitative Analysis 
LC-MS data was analyzed in Xcalibur 2.1 software (Thermo Fisher Scientific, San Jose, 
CA). The peptides and gestrinone were assigned by matching their theoretical masses with the 
actual masses acquired. Extracted ion chromatograms (XICs) were generated by plotting the 
signal of the analyte versus time, using a 0.5 Da mass range for each selected m/z. Table 2 shows 
 
 
Figure 1 Schematic diagram of the post-column infusion experimental set-up used to screen for matrix 
effects, as adapted from reference 9 
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the m/z range used for integration. Peaks were automatically integrated by Xcalibur software and 
manually verified to ensure consistency in integration. A standard curve was then constructed in 
Microsoft Excel by plotting the peak area against the concentration. Linear regression analysis 
was completed to generate the best fit line. Using the best fit line, the concentrations for each of 
the samples in the QC set were experimentally determined, and the accuracy and precision of 
these measurements is reported herein. 
 
2.3 RESULTS AND DISCUSSION 
 
2.3.1 Overview 
 The original goal of this study was to monitor matrix effects experienced by a variety of 
analytes in simple matrices and then to quantify the analytes in these matrices using external 
calibration. While pursuing this goal, unexpectedly poor reproducibility and robustness was 
observed in both the calibration curves and validation sets for two of the four analytes.  An 
investigation into these problems lead to new insights about the challenges in accurately 
predicting whether external calibration would be successful, even when matrix effects are 
verified to be absent.  The data presented here are a case study showing how standard methods of 
measuring matrix effects can provide false hopes that quantitation using external standards could  
 
Table 2 Analyte Characteristics Used in the Study 
 
Analyte 
Monoisotopic 
Mass 
Charge 
State 
m/z range 
monitored 
Linear Range 
(nM) 
Retention 
Time (min) 
YGGFL 555.2766 1 556.0-556.5 100-1000 12.2 
Gestrinone 308.1776 1 309.0-309.5 2-100 19.2 
MRFA 523.2650 2 262.5-263.0 100-1000 8.3 
Bradykinin 1059.5687 3 354.0-354.5 250-1250 9.8 
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be successful:  In our case, accurate quantitation was thwarted because of the autosampler vials 
chosen.   
  
2.3.2 Post-Column Infusion 
 Three peptides, YGGFL, MRFA, and bradykinin, and one steroid, gestrinone, were the 
target analytes in the study.  To determine which of the analytes would experience matrix effects 
upon quantitation with external standards, the method reported by Bonfiglio et al was used
9
.  
Each of the analytes was infused separately with water, BSA digest, lysozyme digest, and a 
mixture of the two digests.  By continuously monitoring the signal of the analyte during co-
infusion of the matrix, matrix effects can be readily detected because they suppress or enhance 
the signal of the analyte.  Matrix effects have been shown to occur most frequently when the 
analyte is at much lower concentrations than the matrix
23
. Consequently the analyte’s 
concentration was chosen to be between 1/20
th 
and 1/100
th
 of the matrices’ concentration in order 
to create optimal conditions for matrix effects to be easily observed.  
Figure 2A shows the total ion chromatogram (TIC) for the post-column infusion of 
bradykinin with a mixture of lysozyme and BSA digests. Figure 2B compares the signal of 
bradykinin infused with the digest mixture to that when it was infused with just the mobile 
phase. The overall signal for both trials increased as the chromatographic run progressed. This 
was expected, due to the increase in organic content of the mobile phase throughout the run. 
Increasing the organic content allows for more of the analyte to become charged because the 
solvent evaporates faster and creates a more stable spray
24
. The signal is approximately the same 
between the two trials except for a dramatic increase slightly after five minutes in the trial with 
matrix infused. This increase was attributed to an interference from the alkylated peptide  
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Figure 2 Post-column infusion chromatograms for bradykinin with tryptic digest mixture A) TIC B) XIC 
of +3 charge state for bradykinin. Infusion with the blank and digest mixture are indicated by the red and 
black lines respectively. Blue line indicates the changes in percent acetonitrile.  These data demonstrate 
that, with the possible exception of the spike at 5 minutes, no matrix effect is observable. 
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Figure 3 MS data for the +3 charge state of bradykinin when co-eluting with a peptide that has a similar 
m/z.  These data were obtained for the peak eluting at ~5.5 minutes in the chromatogram in Figure 2B. 
 
CASIQK
2+
 as can be seen in Figure 3.  Since bradykinin does not co-elute with this peptide (see 
retention times listed in Table 2), no matrix effects were predicted. YGGFL, MRFA, and 
gestrinone produced similar results, which indicated that none of the analytes would experience 
significant matrix effects at their known retention times (data not shown).  
 
2.3.3 Quantitation using Glass Vials 
 Five points were used to establish the calibration curve for each analyte over the selected 
linear range listed in Table 2. Since the post-column infusion experiments indicated that no co-
eluting compounds or matrix effects were present at the retention time of the analytes, the MS 
response was used for quantitation instead of conducting MS/MS experiments and quantifying 
the analytes based on the intensity of product ions. XICs were generated using a 0.5 Dalton 
window around the desired m/z to ensure slight variations in the analyte’s m/z did not negatively 
impact the calibration.  
 The calibration curves for YGGFL, gestrinone, and MRFA all exhibited good linearity 
(R
2
 ≥ 0.992) over the concentration range (Figure 4A, B and C). YGGFL also displayed 
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excellent precision with its %RSD ≤ 2.2 at each point. Although slightly less precise, gestrinone 
and MRFA both had moderately good precision with %RSD ≤ 11.85 and 7.85 respectively. 
Somewhat alarmingly, each analyte displayed a decrease in response between the first and 
second trials, and this trend was the main contributing factor in the lack of precision. 
Bradykinin’s calibration curve is shown in Figure 4D. Bradykinin provided poor linearity 
(R
2
 = 0.9693) over the concentration range. In addition, the level of precision produced was 
extremely poor (%RSD ≥ 42.2). The low precision level is accounted for by a significant loss in 
signal between the first and second trials. 
  The linear equations generated from the calibration curves were used to predict the  
 
 
Figure 4 Calibration curves generated in glass vials 
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concentrations of spiked analytes in tryptic digests. The peptides were spiked to a final 
concentration of 600 nM, while gestrinone was spiked at 60 nM . Table 3 shows the results for 
the analytes in the four different matrices. YGGFL and gestrinone produced acceptable results; 
MRFA had slightly less than ideal results, and bradykinin’s results were completely inaccurate. 
Bradykinin, and to a lesser extent MRFA, exhibited a notable increase in response 
between the water blank and digest matrices. A change in signal between the analyte in a blank 
solution and in the sample matrix is characteristic of a matrix effect. Consequently, upon initial 
analysis of this issue, it appeared that a matrix effect was present, but this phenomenon was 
unobserved in the post-column infusion data. Further investigation led to a hypothesis that 
nonspecific adsorption to the glass injection vials, and not a matrix effect, was the cause of this 
discrepancy.   
Adsorption can occur through numerous types of interactions including hydrophobic or 
electrostatic interactions and hydrogen bonding
25
. Adsorption between a peptide and a solid 
surface occurring through hydrophobic and electrostatic interactions is illustrated in figure 5. 
Since these interactions are specific to each analyte, variations in adsorption between each 
analyte would be expected. Therefore, it is possible that the analytes experienced differential 
degrees of adsorption, and this adsorption would explain the inconsistent calibration results.  
 
Table 3 Experimentally Determined Concentrations for the Quality Control Sets using Glass Vials
a 
Analyte Water BSA digest Lysozyme digest Digest mixture 
YGGFL 667 ± 14 nM 537 ± 42 nM 608 ± 16 nM 553 ± 26 nM 
Gestrinone 67 ± 3 nM 57 ± 1 nM 63 ± 3 nM 43 ± 4 nM 
MRFA 554 ± 47 nM 827 ± 22 nM 825 ± 21 nM 819 ± 39 nM 
Bradykinin 972 ± 604 nM 2830 ± 440 nM 2090 ± 194 nM 19400 ± 16100 nM 
a
Two QC samples were run for each analyte/matrix pair.  Peptide concentrations were 600 nM, while 
gestrinone’s concentration was 60 nM. 
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Figure 5 Interactions between a peptide with both hydrophobic and ionic regions and a solid surface. A. 
Adsorption with an ionic surface B. Adsorption with a hydrophobic surface. Adapted from reference 27. 
 
The dramatic decrease in signal between trial one and trial two for bradykinin, and to a  
lesser extent, for the other three analytes further bolsters the hypothesis that adsorption was 
occurring. The second trial of samples sat in the autosampler for a longer time, because they 
were run after the entire initial round of samples and QC standards were run. The increased 
exposure time between the analytes and the vials’ interior surface could have allowed more of 
the adsorptive interactions to take place prior to the re-analysis of the samples. 
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The vial adsorption hypothesis also offers an explanation for the overestimation of the 
concentration of bradykinin in the (blank) water sample, which would not be explained by matrix 
effects. Trial 1 of the control sample was predicted to have a concentration of over 2.5 times the 
theoretical amount, while trial 2 predicted slightly above half of the theoretical concentration. 
The trial 1 QC was almost immediately sampled while the trial 2 QC sample spent an additional 
9 hours in the autosampler, leading to changes in adsorption levels as a factor of time, as 
previously explained.  
To explain the increased response between the control samples and digest matrices for 
bradykinin and MRFA, a careful literature search revealed components of the matrix can cause 
changes in vial adsorption
2, 3,
 
19,
 
26
. Various compounds can disrupt the analyte’s interactions 
with the container’s surface or displace the analyte from the surface leading to an increase of the 
analyte in solution
25
. We hypothesized that these types of changes were occurring, accounting 
for the increased response experienced by bradykinin and MRFA in the samples containing 
matrix.  
 
2.3.4 Quantitation using Polypropylene Vials 
To test the vial adsorption hypothesis and locate the cause of the quantitation inaccuracy, 
bradykinin was injected from polypropylene vials. None of the other vials used in conjunction 
with bradykinin, such as the stock solution storage vial, were altered between the two studies.  
Figure 6A illustrates the resulting calibration curve from analyzing bradykinin in 
polypropylene vials. Using polypropylene vials greatly improved both the linearity (R
2
 ≥ 0.99) 
and precision (%RSD ≤ 20.5) of the method. However the best fit line goes slightly below the 
origin, indicating that some adsorption may still be taking place.  
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The QC set in polypropylene vials exhibited vast improvements in both the accuracy and 
precision for bradykinin (Table 4). The concentration of the control sample was predicted within 
6% of the theoretical concentration compared to previous overestimate which was greater than 
62%. Additionally the precision was greatly enhanced from the previous RSD values of 62.1% to 
slightly less than 2%. Despite the improvement of accuracy and precision levels in all three of 
the digest matrices, the concentration of bradykinin was still slightly overestimated. Again this 
could be due to some small remaining adsorption interactions between bradykinin and the 
interior surface of the vial.  
Due to the dramatic improvements seen for bradykinin, MRFA was also analyzed in 
polypropylene vials. The calibration curve (Figure 6B) generated in polypropylene vials offered 
slightly less linearity than in the glass vials, but the R
2
 value was still greater than 0.99. Table 4 
shows the QC set results for MRFA in polypropylene vials. Accuracy was improved using 
polypropylene vials in the water, BSA digest, and lysozyme digest matrices when compared to 
the glass vials. In the BSA digest matrix and the lysozyme digest matrix accuracy was improved 
from approximately a 38% overestimate to within 13% of the theoretical concentration. The 
concentration in the digest mixture still fell outside of an acceptable range of error, and an  
 
Figure 6 Calibration curves generated in polypropylene vials 
y = 1345.2x - 191186 
R² = 0.9914 
0.0E+00
4.0E+05
8.0E+05
1.2E+06
1.6E+06
0 400 800 1200
P
ea
k
 A
re
a
 
Concentration (nM) 
A. Bradykinin 
y = 5326.3x + 55374 
R² = 0.9965 
0.00E+00
2.00E+06
4.00E+06
6.00E+06
8.00E+06
0 400 800 1200
P
ea
k
 A
re
a
 
Concentration (nM) 
B. MRFA 
74 
 
Table 4 Experimentally Determined Concentrations for the Quality Control Sets in Polypropylene Vials
a 
Analyte Water BSA digest Lysozyme digest Digest mixture 
Bradykinin 635 ± 9 nM 755 ± 28 nM 756 ± 10 nM 775 ± 65 nM 
MRFA 650 ± 39 nM 506 ± 15 nM 572 ± 31 nM 331 ± 15 nM 
a
Two QC samples were run for at 600 nM for each analyte/matrix pair. 
 
additional investigation would have to be completed to determine the source of this inaccuracy. 
The improvements in accuracy observed from switching bradykinin and MRFA from 
glass injection vials to polypropylene injection vials demonstrated that adsorptive interactions 
were the main source of the errors during the external calibration method. Since adsorption 
interactions are unique between a particular analyte and vial material, testing bradykinin’s 
quantitative results using other injection vial materials may offer further improvement, allowing 
the method to fall within the desired ±15% range. When nonspecific adsorption is masquerading 
as a matrix effect, it can be difficult to identify. However this study demonstrates the importance 
of testing for vial adsorption if a matrix effect appears to be skewing the quantitative results, 
even after one has experimentally determined matrix effects to be absent.  Errors in quantitation 
due to vial adoption can be easily minimized by changing the material that is interacting with the 
analytes.  
 Predicting the vial material that is most suitable for each compound could also help 
alleviate quantitative inaccuracy. Since vial and analyte interactions are dominated by 
hydrophobic and electrostatic interactions, studying a compound’s hydrophobicity using its 
partition coefficient (log P), and its isoelectric point (pI) could prove to be beneficial. These two 
properties for the compounds in this study are listed in Table 1. Bradykinin and MRFA have pI 
values of 11.97 and 10.00 respectively, meaning they will have a positive charge at the pH of all 
the matrices used in this experiment. The structure of glass and polypropylene are shown in 
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figure 7. Glass has a negative charge at the surface while polypropylene is neutral leading to 
Bradykinin and MRFA having a more favorable interaction with glass than with polypropylene. 
Although isoelectric points seem to explain the adsorption trend for the small set of analytes 
presented in this study, a larger assortment of compounds will most likely show that a  
combination of hydrophobicity and charge account for non-specific adsorption.  
 
 
 
Figure 7 A. Crystalline structure of glass B. Structure of polypropylene. Adapted from reference 28. 
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2.4 CONCLUSION 
Our investigation sought to understand the source of some inaccuracies experienced 
during external calibration methods. A pre-screen for matrix effects was accomplished using 
standard literature procedures and ion suppression and enhancement was not observed for any of 
the analytes in our study. Despite the lack of detected matrix effects, an apparent matrix effect 
was observed when calibration curves were generated and QC samples were analyzed.  This 
apparent matrix effect for bradykinin and, to a lesser extent, MRFA, was eventually ascribed to 
vial absorption.  The results from our study indicate that vial adsoption can be a significant factor 
in obtaining high quality quantitative analyses, and addressing this issue is straightforward, if 
investigators know to check for the problem.  Although the analytes in our study only represent a 
very small sum of compounds analyzed by LC-MS, they adequately portray the variable success 
rate for different analytes using external calibration. The unique source of inaccuracy for  
bradykinin provides an important reminder to those doing quantitative analysis that glass 
autosampler vials are not inert, and they may interfere with some analyses. 
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CHAPTER 3 
FUTURE OUTLOOK 
ABSTRACT 
 Every compound targeted during a quantitative analysis experiences distinct interactions 
with the sample matrix and the many surfaces encountered during experimentation. These 
interactions play a crucial role in determining the success of the analysis. Quantitative analysis 
via liquid chromatography-mass spectrometry (LC-MS) is specifically affected by interactions 
occurring during the ionization stages of analysis, known as matrix effects, and adsorption 
interactions that occur during sample handling. This study is a follow up to our previous 
investigation and includes case studies for additional peptides noting their differences with 
regards to matrix effects and vial adsorption interactions. A description of future experiments 
necessary to increase the success of LC-MS external calibration quantitative methods is also 
presented. 
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3.1 INTRODUCTION 
 Every quantitation application results in a unique blend of interactions between the target 
analyte, sample matrix, and surfaces encountered during the analysis. These interactions are 
crucial during multiple steps of method development including instrument selection, sample 
preparation, and optimization parameters. When liquid chromatography-mass spectrometry (LC-
MS) is chosen as the analytical technique, two additional areas affected by analyte and matrix 
interactions are ionization efficiency and vial recovery. 
 There are many mechanistic theories attempting to describe the interactions between the 
analyte and matrix that can lead to changes in ionization efficiency. These mechanisms are 
dependent on the type of ionization source used. Electrospray ionization (ESI) couples the LC to 
the mass spectrometer and creates ions by applying an electrical charge to the liquid phase which 
produces charged droplets via Taylor cone formation (Figure 1)
1
.  Subsequent solvent 
evaporation and droplet fission allows the analyte to reach the gas phase as an ion
2
. Interactions 
in both the liquid and gas phases have been theorized to change an analyte’s ionization 
efficiency
3
.  
 
Figure 1 Electrospray ionization mechanism adapted from reference 1 
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The liquid phase is generally described as the primary phase where ionization 
suppression or enhancement occurs. Molecules on the outer surface of a droplet enter the gas 
phase as ions more readily than molecules on the interior of the droplet
4
. An analyte’s placement 
within a droplet is determined by its surface affinity with respect to other droplet components
5
. 
Consequently when matrix compounds are present, they compete with the targeted compound for 
surface space, potentially altering the mass spectrometric response of the analyte
6
.  King et al 
noted two additional mechanisms in the liquid phase that could cause changes in ionization
7
. 
Changes in droplet properties, such as surface tension or boiling point, could affect solvent 
evaporation lowering gas phase analyte ion production. Non-volatile matrix or mobile phase 
components could precipitate from the droplets, encompassing analyte molecules within the solid 
particles. Although the gas phase is not the principal source of adverse interactions, charge 
transfer or neutralization reactions could alter the amount of analyte ions that reach the detector
8
. 
 Nonspecific adsorption is also another phenomenon that presents a challenge to 
quantitation using LC-MS. Adsorption occurs when it is either entropically or enthalpically 
favorable for the analyte to interact with the solid surface
9
.  Electrostatic and hydrophobic 
interactions are generally cited as the primary factors governing adsorption
10
. Increasing 
exposure time incorporates unpredictability to adsorption. When a solution is first introduced to a 
surface, adsorption/desorption interactions are reversible causing a pseudo-equilibrium between 
the surface and analyte, but as time progresses adsorption interactions can cause the analyte to 
undergo conformational changes allowing for stronger bonds with the surface lowering the level 
of desorption
9
. Figure 2 illustrates how competition for surface space and surface displacement 
can be caused by compounds in the solution with a higher surface affinity. This phenomenon is 
known as the Vroman effect
11
 and adds to the difficulty of evaluating adsorption interactions. 
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Figure 2 A. Analyte adsorption in a blank solution B. Analyte adsorption with competing matrix 
components 
 
 
The lack of knowledge regarding both matrix effects and nonspecific adsorption makes 
incorporating them into a quantitative method a challenge. This investigation illustrates the 
variety of analyte and matrix interactions and their role in quantitation accuracy. It is meant as a 
brief follow-up to our previous study detailed in Chapter 2 and provides a reflection of future 
changes and experimentation necessary to improve external calibration quantitative results. 
 
3.2 EXPERIMENTAL 
  
3.2.1 Materials and Reagents 
Angiotensin I human acetate salt hydrate and insulin from bovine pancreas were obtained 
from Sigma-Aldrich (St Louis, MO). Stock solutions of angiotensin I and insulin were prepared 
in 50:50 methanol to water with 0.1% formic acid with concentrations of 50µM and 200µM 
respectively. Stock solutions were stored at -20°C until use. Additional details regarding 
materials and reagents, tryptic digestion, and sample preparation can be found in the 
experimental section of chapter 2. 
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3.2.2 LC-MS Analysis 
Multiple LC-MS instruments were used throughout this study due to the availability of 
each instrument. 
 
3.2.2.1 Insulin 
A nanoACQUITY UltraPerformance LC system (Waters Acquity, Milford, MA) 
equipped with a Hypersil GOLD column (C18, 100 mm X 1.0 mm i.d., 5 µM, 175 Å; Thermo 
Scientific, San Jose, CA) was used for the insulin experiments. The insulin calibration standards 
and quality control (QC) samples were injected with a volume of 5µL. Mobile phase A was 
99.9% water and 0.1% formic acid and mobile phase B was 99.9% acetonitrile and 0.1% formic 
acid. Gradient elution at a flow rate of 15µL/min was used with mobile phase B starting at 2%, 
then increased to 60% over 24 minutes and held there for 2 minutes. At the end of each run, the 
column was reequilibrated for 4 minutes with a mobile phase B concentration of 2%. A water 
blank was included after each sample to eliminate potential analyte carryover. 
An LTQ-FTICR hybrid mass spectrometer (Thermo Scientific, San Jose, CA) was 
coupled to the LC system via an electrospray ionization source. The source was operated in 
positive ion mode with a spray voltage of 2.80 kV and a capillary temperature of 200°C. MS
1 
data was collected using the FT mass analyzer with the resolution set at 25000 for an m/z range 
of 400 to 2000. The three most intense ions in MS
1
 were subjected to collision induced 
dissociation (CID) in the linear ion trap to generate MS/MS data. For CID, the precursor ion 
width was set at 2 Da with a normalized collision energy of 35%. 
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3.2.2.2 Angiotensin I and YGGFL 
 YGGFL was injected into the LC-MS system from polypropylene injection vials. Two 
trials were completed for angiotensin I; one from glass vials, and the second from polypropylene 
vials. Instrumentation parameters were used exactly as described in section 2.2.4. 
 
3.2.3 Post-Column Infusion 
 The post-column infusion system was set-up as previously described in section 2.2.5 
Briefly, 5µL of digested BSA or lysozyme was injected into the LC-MS system. Insulin and 
angiotensin I were consecutively infused with the LC eluent via a T splitter and the flow was 
directed toward the ESI source. Both peptides had a concentration at the source of 100nM. MS
1
 
data was analyzed to determine the peptide’s signal fluctuation throughout the run. 
 
3.2.4 Data Analysis 
 Data analysis was completed using Xcalibur 2.1 software (Thermo Fisher Scientific, San 
Jose, CA). Calibration curves were constructed by plotting concentration against peak area in 
Microsoft Excel. Peak areas were determined by integrating extracted ion chromatograms (XICs) 
created using the desired m/z in MS
1
. The best fit line was generated using linear regression 
analysis. It was then used to predict experimental concentrations for the validation set. 
 
Table 1. Analyte Characteristics 
Analyte 
Monoisotopic 
Mass 
Charge 
State 
m/z range 
monitored 
Linear 
Range (nM) 
Retention 
Time (min) 
Insulin 5729.6009 5 1146.75-1147.25 100-1240 17.9 
Angiotensin I 1296.6848 2 648.5-649 500-1500 11.4 
YGGFL 555.2766 1 556.0-556.5 100-1000 12.2 
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3.3 RESULTS AND DISCUSSION 
 
3.3.1 Overview 
 External calibration was completed for insulin, angiotensin I, and YGGFL using the m/z 
values and concentration ranges detailed in Table 1. The chemical characteristics and structures 
of insulin and angiotensin I are shown in Table 2. The external calibration method was evaluated 
with regards to each analyte and injection vial material. Future improvements and experiments 
are presented at the conclusion of each subsection.  
 
3.3.2 Insulin 
 The +4, +5, and +6 charge states of insulin were observed in the full mass spectrum. In 
these studies, the +5 charge state was the most intense and was chosen for the quantitative 
analysis. Insulin was infused with BSA and lysozyme digests consecutively.  As can be seen in 
Figure 3 and Figure 4, no ion suppression or enhancement was experienced by the +5 charge 
state of insulin throughout the entire chromatographic run. 
 
Table 2. Properties of Anigotensin I and Insulin
 
 
Compound 
Angiotensin I 
Insulin 
log P Sequence pI 
9.06 
5.30 
-1.1 
-12.8 
NRVYIHPFHL 
GIVEQCCASVCSLYQLENYCN 
FVNQHLCGSHLVEALYVCGERGFFYTPKA 
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Figure 3 Post-column infusion chromatograms for BSA digest with insulin A) TIC  B) XIC of +5 charge 
state of insulin. Infusion with the blank and BSA are indicated by the red and black lines respectively. 
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Figure 4 Post-column infusion chromatograms for lysozyme digest with insulin. A) TIC  B) XIC of +5 
charge state of insulin. Infusion with the blank and lysozyme are indicated by the red and black lines 
respectively. 
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Figure 5 Insulin calibration curves in glass and polypropylene vials 
 
 
 
The calibration curves for insulin are shown in Figure 5. There are many notable 
differences between the polypropylene and glass vials standard curves; the foremost being that 
an exponential equation instead of a linear equation represents the best-fit line using the glass 
vials. Upon closer examination of this issue, the overall response using the glass vials is 
significantly lower than the response using polypropylene vials. For example, the 680nM 
standard gives a response over 6 fold lower in glass vials than in polypropylene. The significant 
response difference is attributed to insulin adsorbing to the glass vial. This effect results in the 
linear range being slightly higher in the glass vials, which causes the data points to fall below the 
linear range leading to an exponential fit. Additionally the 100nM standard fell below the linear  
range when using the polypropylene vials, so it was not included in the standard curve.  
The best fit equation generated by analyzing the samples in the polypropylene vials had 
good linearity and reproducibility. However switching to the glass vials caused the 
reproducibility to decrease due to more adsorption interactions taking place between trial 1 and 
trial 2. In the glass vials, the R
2
 value was not ideal, but this can be accounted for by 
experimental error. The last point on the standard curve (1240nM), was lower than expected 
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91 
 
because the nitrogen gas ran out on the initial trial of this sample and this concentration was 
repeated at a later time altering the exposure time to the vial.  
The theoretical concentration of insulin was 750nM in each of the QC samples. As can be 
seen in Table 3, the accuracy and precision using polypropylene vials is very good, but using 
glass vials yields unacceptable results.  Since 750nM in not within the linear range when using 
glass vials these results are not surprising. Additionally, while using the glass injection vials 
there is over a 45% difference for the concentrations predicted in water and the various digest 
matrices. However, when using the polypropylene vials the concentrations are all predicted 
within 15% of each other. This change is hypothesized to be from competition between the 
matrix and analyte for adsorption sites on the vial’s interior, causing an increase in solution for 
insulin. These results are consistent with those experienced by bradykinin, described in chapter 
2, however they do not follow the trend described with the isoelectric point. 
The calibration standards and QC samples for the insulin experiments were completed 
using an LTQ-FTICR mass spectrometer. Since this mass spectrometer is a high resolution 
instrument, it allowed for easy determination of the various charge states from the MS
1
 mode and 
incorporation of a specific number of isotope peaks during integration. However, this instrument 
was not able to achieve the low detection limits obtained by using the LTQ Velos mass 
spectrometer that was used for the other analytes. Preliminary data (not shown) using the LTQ 
Velos predicted the linear range in glass vials to start at 50nM, significantly lower than the linear 
range for polypropylene vials obtained using the LTQ-FTICR. Consequently additional 
experiments using an LTQ Velos instrument should result in an even lower linear range using the 
polypropylene injection vials 
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Table 3 Experimentally Determined Concentrations for the Quality Control Sets of 750 nM Insulin 
Vial Water BSA digest Lysozyme digest Digest mixture 
PP* (n=2) 731 ± 23 nM 696 ± 20 nM 806 ± 3 nM 707 ± 16 nM 
Glass (n=2)
 
603 ± 81 nM 1100 ± 15 nM 944 ± 44 nM 1020 ± 2 nM 
*Polypropylene 
 
3.3.3 Angiotensin I 
 The +2 charge state of angiotensin I was selected as the target ion for data analysis. The 
results of the post-column infusion of angiotensin I with both the BSA digest (Figure 6) and the 
lysozyme digest (Figure 7) showed significant signal enhancement around the retention time of 
angiotensin I. This was due to co-eluting tryptic peptides from the digest matrices with 
overlapping m/z values and not from changes in ionization efficiency resulting from the matrix. 
Similar results were obtained when monitoring the other observed charge states of angiotensin I.
 Before this problem was discovered, the calibration and validation samples in both glass 
and polypropylene injection vials were tested (data not shown). In the glass vials, there was a 
decrease in signal between the first and second trials although this was not experienced in the 
polypropylene vials. However neither set of standards provided a calibration curve with ideal 
linearity (R
2
 ≥ 0.99).  When it came to the QC sets, peak integration was a challenge; it was often 
impossible to obtain an area representative only of angiotensin.  Consequently the QC data did 
not give an accurate representation of the actual concentration of angiotensin I and is not 
reported. Figure 8 shows the poor chromatographic resolution between angiotensin and other co-
eluting peptides with the same m/z.  This data was obtained when angiotensin I was spiked in the 
BSA and lysozyme digestion mixture. Before matrix effects or adsorption studies can be 
completed, a quantitation method that has a higher likelihood for success needs to be generated. 
Resolution between angiotensin I and matrix components with similar m/z values and/or the  
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Figure 6 Post-column infusion chromatograms for BSA digest with Angiotensin I. A) TIC  B) XIC of +2 
charge state of Angiotensin I. Infusion with the blank and BSA are indicated by the red and black lines 
respectively. 
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Figure 7 Post-column infusion chromatograms for lysozyme digest with Angiotensin I. A) TIC  B) XIC 
of +2 charge state of Angiotensin I. Infusion with the blank and lysozyme are indicated by the red and 
black lines respectively. 
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Figure 8 XIC of Angiotensin I with co-eluting peptides with similar m/z values 
 
method’s selectively need to be enhanced. 
Resolution can be improved by altering the chromatographic conditions employed for the 
experiment. Although there are many parameters that can enhance resolution including 
lengthening the run time, increasing the flow rate, altering temperature, and lengthening the  
column, these factors only make minute changes in resolution. Decreasing the slope of the 
gradient is effective in some instances to resolve peaks, but other times it can cause additional 
overlap
12
. Testing various slopes and their effect on angiotensin’s resolution could prove to be 
advantageous. Due to the extreme amount of peak overlap experienced by angiotensin I, utilizing 
a different stationary phase which can distinguish angiotensin I from the matrix components is 
the most likely way to enhance resolution. Phenyl, C18, and C4 columns have been shown to alter 
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the retention time of angiotensin I and could offer increased resolution for this experiment
12
.  
Selectivity can be improved by changing the mass spectrometric parameters. In this experiment, 
peaks were integrated from MS
1
 data. Single reaction monitoring (SRM) monitors one or more 
ions resulting from fragmentation of a particular precursor m/z value
13
. Picking a precursor to 
product ion transition that is specific to angiotensin I would offer an increase in selectivity and 
potentially eliminate interferences from peptides with the same precursor m/z. Although such 
changes were not made, they would be beneficial in future studies involving angiotensin I. 
 
3.3.4. YGGFL  
 The calibration and validation samples for YGGFL were analyzed from polypropylene 
injection vials. The calibration standards showed a slight decrease between trials one and two 
(Table 4) indicating that some adsorption may be occurring. Additionally the 750 nM and 1000 
nM standards in trial one (highlighted in yellow in Table 4) were significantly lower than 
expected. The injection volume was determined for both the 750nM and 1000nM samples by 
measuring the volume of sample remaining after the injection was completed, and it was found 
they were injected at a much lower volume than desired. This could have been a result of an 
unobserved air bubble present in the sample or an instrument malfunction. Consequently those 
two values were not used to generate the calibration curve. The calibration curve was constructed 
by plotting peak area against concentration. An average of the peak area for trials one and two 
were used for the concentrations of 100 nM, 250 nM, and 500 nM, but only trial two was used 
for 750 nM and 1000 nM. As a result, the linearity is not ideal (R
2
 = 0.9209) because the 750nM 
and 1000nM data points are slightly lower than expected, altering the best fit line’s placement 
(Figure 9).  
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Table 4 Peak area for YGGFL’s calibration standards 
Concentration (nM) Trial 1 Area Trial 2 Area Average Area 
100 38672 12696 25684 
250 1461817 1209704 1335761 
500 4564226 2411847 3488037 
750 730900
*
 3515206 2123053 
1000 728423 4978353 2853388 
* 
highlighting indicts an improper injection 
 
The concentration predictions for the QC set exhibited good accuracy and precision 
(Table 5). Aside from trial 1 in the BSA digest, all of the trials were predicted within 8% of the 
theoretical value (600 nM) with % RSD values ≤ 8.5. Trial 1 in the BSA digest matrix 
experienced an improper injection therefore the results for the BSA digest are reported as trials 1 
and 2 separately. Although the accuracy is comparable between glass (as reported in chapter 2) 
and polypropylene vials, the precision is better in all instances using the glass vials. The lack of 
precision is due to the decrease between trial 1 and trial 2 attributed to adsorptive interactions 
with the polypropylene vial. Interestingly, YGGFL is the only analyte in our study that produced  
 
 
Figure 9 YGGFL Calibration Curve in Polypropylene Vials 
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better results using glass injection vials than polypropylene. This observation highlights the 
variability in analyte and vial interactions indicating the importance of optimizing sample 
containers for each analyte during a quantitation study. 
An internal standard could be used to account for variable injection volumes such as the 
ones that were experienced during this experiment. However since this problem was rare with 
regards to the numerous trials completed for other analytes, it would be more time efficient to 
rerun the samples that were not injected properly than to develop a sufficient internal standard. 
 
3.3.5 Future Analytes 
There are many other classes of compounds that can be quantified using LC-MS besides 
the protein/peptide category focused on in this particular study. Many of these compounds 
exhibit ionic or hydrophobic characteristics that have been associated with adsorptive 
interactions. Small molecule drugs have been noted to experience both adsorption interactions
14
 
and matrix effects
15
. Gestrinone, a particularly hydrophobic steroid, could be quantified using 
polypropylene injection vials and the results compared to those obtained using glass vials as 
described in chapter 2. The information gathered could be used as a starting point to analyze the 
effects injection vials have on small molecules.  
 
Table 5 Experimentally Determined Concentrations for the Quality Control Sets of 600 nM YGGFL 
Vial Water BSA digest‡ Lysozyme digest Digest mixture  
PP* (n=2) 632 ± 33 nM 9.24/107 nM 612 ± 50 nM 604 ± 29 nM 
Glass
†
 (n=2) 667 ± 14 nM 537 ± 42 nM 608 ± 16 nM 553 ± 26 nM 
*Polypropylene 
†
 Study taken from Chapter 2 
‡
 Accuracy is reported for trial 1 and 2 in polypropylene vials to show how trial 1 was effected by an 
improper injection. Accuracy reported for glass vials remains the average of trials 1 and 2. 
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3.4 CONCLUSION 
 
 Analyte and matrix interactions have been shown to alter LC-MS quantitation accuracy. 
These interactions are unique to a specific analyte and matrix pair as we have highlighted in this 
study. Although matrix effects with respect to ionization efficiency are frequently evaluated 
during method development, nonspecific adsorption is rarely considered. This aspect of analyte 
and matrix interactions needs to be incorporated into the method development stages of LC-MS 
external calibration quantitation studies. 
 Our study only compared analyte and matrix interactions with injection vials; however 
other surfaces encountered during quantitative analysis could also be affected by variable 
adsorption. Several surfaces that have been noted to experience adsorption and loss of analyte 
such as storage containers
16
, connective tubing
17
, and various parts of the injection system 
including the needle
18
, value rotor seal
19
, and injection loop
14
. A thorough investigation of 
adsorption to these surfaces would encompass not only an analyte’s interactions with the 
material in question, but how that interaction is altered by the addition of the sample matrix. 
Glass and polypropylene were the only materials assessed during this study. Injection 
vials are also made out of many other materials including deactivated glass, amber glass, 
polystyrene, polyethylene, polymethylpentene, and polytetrafluoroethylene. Utilizing injection 
vials made from these materials could provide additional quantitation accuracy and precision. 
Additives can also be applied to coat the vial’s interior and reduce adsorption. Examining a 
variety of such compounds could also improve a method’s accuracy and precision. 
The accuracy of an external calibration method hinges upon consistent measurements 
obtained by the LC-MS system. Therefore, when measurements are hindered by one of the 
previously explained mechanisms, the accuracy of the method is expected to be low. However, 
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thoroughly investigating potential error sources and tweaking the quantitation method if 
necessary will create successful external calibration techniques capable of both high accuracy 
and precision. 
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